151
|
Smith A, Moorhouse E, Monaghan J, Taylor C, Singleton I. Sources and survival of Listeria monocytogenes on fresh, leafy produce. J Appl Microbiol 2018; 125:930-942. [PMID: 30039586 DOI: 10.1111/jam.14025] [Citation(s) in RCA: 45] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2018] [Revised: 05/31/2018] [Accepted: 06/18/2018] [Indexed: 12/26/2022]
Abstract
Listeria monocytogenes is an intracellular human pathogen which enters the body through contaminated food stuffs and is known to contaminate fresh leafy produce such as spinach, lettuce and rocket. Routinely, fresh leafy produce is grown and processed on a large scale before reaching the consumer through various products such as sandwiches and prepared salads. From farm to fork, the fresh leafy produce supply chain (FLPSC) is complex and contains a diverse range of environments where L. monocytogenes is sporadically detected during routine sampling of produce and processing areas. This review describes sources of the bacteria in the FLPSC and outlines the physiological and molecular mechanisms behind its survival in the different environments associated with growing and processing fresh produce. Finally, current methods of source tracking the bacteria in the context of the food supply chain are discussed with emphasis on how these methods can provide additional, valuable information on the risk that L. monocytogenes isolates pose to the consumer.
Collapse
Affiliation(s)
- A Smith
- School of Applied Sciences, Edinburgh Napier University, Edinburgh, UK
| | | | - J Monaghan
- Crop and Environment Sciences, Harper Adams University, Newport, UK
| | - C Taylor
- School of Applied Sciences, Edinburgh Napier University, Edinburgh, UK
| | - I Singleton
- School of Applied Sciences, Edinburgh Napier University, Edinburgh, UK
| |
Collapse
|
152
|
Warner R, Pottle E, Taylor C, Green J. The urology cancer MDT; What can be improved? Int J Surg 2018. [DOI: 10.1016/j.ijsu.2018.05.636] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
153
|
Abstract
This article highlights important developments in the character of temporary worker flows to Canada between 1973 and 1985 through the use of unpublished data and new measures for analyzing this data. The number of employment authorizations are converted to person years to indicate the overall labor market impact of temporary worker flows and this measure is employed in an analysis of unpublished data from Employment and Immigration Canada. The analysis reveals that a significant and growing proportion of employment authorizations are exempted from governmental procedures which link the admission of temporary workers to the Canadian labor market. In many cases, these exempt documents are being authorized for social and humanitarian programs (e.g., refugee claimants, in-Canada immigrant claimants). As a result, the actual “labor recruitment” component of these authorizations is considerably less than interpreted from published statistics of employment authorizations. The policy implications of these findings are discussed.
Collapse
Affiliation(s)
| | - Chris Taylor
- Immigration Policy Development, Employment and Immigration Canada, Place du Portage, Phase IV
| | - Paul Delaney
- Immigration Policy Development, Employment and Immigration Canada, Place du Portage, Phase IV
| |
Collapse
|
154
|
Tang WW, McGee P, Lachin JM, Li DY, Hoogwerf B, Hazen SL, Nathan D, Zinman B, Crofford O, Genuth S, Brown‐Friday J, Crandall J, Engel H, Engel S, Martinez H, Phillips M, Reid M, Shamoon H, Sheindlin J, Gubitosi‐Klug R, Mayer L, Pendegast S, Zegarra H, Miller D, Singerman L, Smith‐Brewer S, Novak M, Quin J, Genuth S, Palmert M, Brown E, McConnell J, Pugsley P, Crawford P, Dahms W, Gregory N, Lackaye M, Kiss S, Chan R, Orlin A, Rubin M, Brillon D, Reppucci V, Lee T, Heinemann M, Chang S, Levy B, Jovanovic L, Richardson M, Bosco B, Dwoskin A, Hanna R, Barron S, Campbell R, Bhan A, Kruger D, Jones J, Edwards P, Bhan A, Carey J, Angus E, Thomas A, Galprin A, McLellan M, Whitehouse F, Bergenstal R, Johnson M, Gunyou K, Thomas L, Laechelt J, Hollander P, Spencer M, Kendall D, Cuddihy R, Callahan P, List S, Gott J, Rude N, Olson B, Franz M, Castle G, Birk R, Nelson J, Freking D, Gill L, Mestrezat W, Etzwiler D, Morgan K, Aiello L, Golden E, Arrigg P, Asuquo V, Beaser R, Bestourous L, Cavallerano J, Cavicchi R, Ganda O, Hamdy O, Kirby R, Murtha T, Schlossman D, Shah S, Sharuk G, Silva P, Silver P, Stockman M, Sun J, Weimann E, Wolpert H, Aiello L, Jacobson A, Rand L, Rosenzwieg J, Nathan D, Larkin M, Christofi M, Folino K, Godine J, Lou P, Stevens C, Anderson E, Bode H, Brink S, Cornish C, Cros D, Delahanty L, eManbey ., Haggan C, Lynch J, McKitrick C, Norman D, Moore D, Ong M, Taylor C, Zimbler D, Crowell S, Fritz S, Hansen K, Gauthier‐Kelly C, Service F, Ziegler G, Barkmeier A, Schmidt L, French B, Woodwick R, Rizza R, Schwenk W, Haymond M, Pach J, Mortenson J, Zimmerman B, Lucas A, Colligan R, Luttrell L, Lopes‐Virella M, Caulder S, Pittman C, Patel N, Lee K, Nutaitis M, Fernandes J, Hermayer K, Kwon S, Blevins A, Parker J, Colwell J, Lee D, Soule J, Lindsey P, Bracey M, Farr A, Elsing S, Thompson T, Selby J, Lyons T, Yacoub‐Wasef S, Szpiech M, Wood D, Mayfield R, Molitch M, Adelman D, Colson S, Jampol L, Lyon A, Gill M, Strugula Z, Kaminski L, Mirza R, Simjanoski E, Ryan D, Johnson C, Wallia A, Ajroud‐Driss S, Astelford P, Leloudes N, Degillio A, Schaefer B, Mudaliar S, Lorenzi G, Goldbaum M, Jones K, Prince M, Swenson M, Grant I, Reed R, Lyon R, Kolterman O, Giotta M, Clark T, Friedenberg G, Sivitz W, Vittetoe B, Kramer J, Bayless M, Zeitler R, Schrott H, Olson N, Snetselaar L, Hoffman R, MacIndoe J, Weingeist T, Fountain C, Miller R, Johnsonbaugh S, Patronas M, Carney M, Mendley S, Salemi P, Liss R, Hebdon M, Counts D, Donner T, Gordon J, Hemady R, Kowarski A, Ostrowski D, Steidl S, Jones B, Herman W, Martin C, Pop‐Busui R, Greene D, Stevens M, Burkhart N, Sandford T, Floyd J, Bantle J, Flaherty N, Terry J, Koozekanani D, Montezuma S, Wimmergren N, Rogness B, Mech M, Strand T, Olson J, McKenzie L, Kwong C, Goetz F, Warhol R, Hainsworth D, Goldstein D, Hitt S, Giangiacomo J, Schade D, Canady J, Burge M, Das A, Avery R, Ketai L, Chapin J, Schluter M, Rich J, Johannes C, Hornbeck D, Schutta M, Bourne P, Brucker A, Braunstein S, Schwartz S, Maschak‐Carey B, Baker L, Orchard T, Cimino L, Songer T, Doft B, Olson S, Becker D, Rubinstein D, Bergren R, Fruit J, Hyre R, Palmer C, Silvers N, Lobes L, Rath PP, Conrad P, Yalamanchi S, Wesche J, Bratkowksi M, Arslanian S, Rinkoff J, Warnicki J, Curtin D, Steinberg D, Vagstad G, Harris R, Steranchak L, Arch J, Kelly K, Ostrosaka P, Guiliani M, Good M, Williams T, Olsen K, Campbell A, Shipe C, Conwit R, Finegold D, Zaucha M, Drash A, Morrison A, Malone J, Bernal M, Pavan P, Grove N, Tanaka E, McMillan D, Vaccaro‐Kish J, Babbione L, Solc H, DeClue T, Dagogo‐Jack S, Wigley C, Ricks H, Kitabchi A, Chaum E, Murphy M, Moser S, Meyer D, Iannacone A, Yoser S, Bryer‐Ash M, Schussler S, Lambeth H, Raskin P, Strowig S, Basco M, Cercone S, Zinman B, Barnie A, Devenyi R, Mandelcorn M, Brent M, Rogers S, Gordon A, Bakshi N, Perkins B, Tuason L, Perdikaris F, Ehrlich R, Daneman D, Perlman K, Ferguson S, Palmer J, Fahlstrom R, de Boer I, Kinyoun J, Van Ottingham L, Catton S, Ginsberg J, McDonald C, Harth J, Driscoll M, Sheidow T, Mahon J, Canny C, Nicolle D, Colby P, Dupre J, Hramiak I, Rodger N, Jenner M, Smith T, Brown W, May M, Lipps Hagan J, Agarwal A, Adkins T, Lorenz R, Feman S, Survant L, White N, Levandoski L, Grand G, Thomas M, Joseph D, Blinder K, Shah G, Burgess D, Boniuk I, Santiago J, Tamborlane W, Gatcomb P, Stoessel K, Ramos P, Fong K, Ossorio P, Ahern J, Gubitosi‐Klug R, Meadema‐Mayer L, Beck C, Farrell K, Genuth S, Quin J, Gaston P, Palmert M, Trail R, Dahms W, Lachin J, Backlund J, Bebu I, Braffett B, Diminick L, Gao X, Hsu W, Klumpp K, Pan H, Trapani V, Cleary P, McGee P, Sun W, Villavicencio S, Anderson K, Dews L, Younes N, Rutledge B, Chan K, Rosenberg D, Petty B, Determan A, Kenny D, Williams C, Cowie C, Siebert C, Steffes M, Arends V, Bucksa J, Nowicki M, Chavers B, O'Leary D, Polak J, Harrington A, Funk L, Crow R, Gloeb B, Thomas S, O'Donnell C, Soliman E, Zhang Z, Li Y, Campbell C, Keasler L, Hensley S, Hu J, Barr M, Taylor T, Prineas R, Feldman E, Albers J, Low P, Sommer C, Nickander K, Speigelberg T, Pfiefer M, Schumer M, Moran M, Farquhar J, Ryan C, Sandstrom D, Williams T, Geckle M, Cupelli E, Thoma F, Burzuk B, Woodfill T, Danis R, Blodi B, Lawrence D, Wabers H, Gangaputra S, Neill S, Burger M, Dingledine J, Gama V, Sussman R, Davis M, Hubbard L, Budoff M, Darabian S, Rezaeian P, Wong N, Fox M, Oudiz R, Kim L, Detrano R, Cruickshanks K, Dalton D, Bainbridge K, Lima J, Bluemke D, Turkbey E, der Geest ., Liu C, Malayeri A, Jain A, Miao C, Chahal H, Jarboe R, Nathan D, Monnier V, Sell D, Strauch C, Hazen S, Pratt A, Tang W, Brunzell J, Purnell J, Natarajan R, Miao F, Zhang L, Chen Z, Paterson A, Boright A, Bull S, Sun L, Scherer S, Lopes‐Virella M, Lyons T, Jenkins A, Klein R, Virella G, Jaffa A, Carter R, Stoner J, Garvey W, Lackland D, Brabham M, McGee D, Zheng D, Mayfield R, Maynard J, Wessells H, Sarma A, Jacobson A, Dunn R, Holt S, Hotaling J, Kim C, Clemens Q, Brown J, McVary K. Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study. J Am Heart Assoc 2018. [PMCID: PMC6015340 DOI: 10.1161/jaha.117.008368] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background
Hyperglycemia leading to increased oxidative stress is implicated in the increased risk for the development of macrovascular and microvascular complications in patients with type 1 diabetes mellitus.
Methods and Results
A random subcohort of 349 participants was selected from the
DCCT
/
EDIC
(Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications) cohort. This included 320 controls and 29 cardiovascular disease cases that were augmented with 98 additional known cases to yield a case cohort of 447 participants (320 controls, 127 cases). Biosamples from
DCCT
baseline, year 1, and closeout of
DCCT
, and 1 to 2 years post‐
DCCT
(
EDIC
years 1 and 2) were measured for markers of oxidative stress, including plasma myeloperoxidase, paraoxonase activity, urinary F
2α
isoprostanes, and its metabolite, 2,3 dinor‐8
iso
prostaglandin F
2α
. Following adjustment for glycated hemoblobin and weighting the observations inversely proportional to the sampling selection probabilities, higher paraoxonase activity, reflective of antioxidant activity, and 2,3 dinor‐8
iso
prostaglandin F
2α
, an oxidative marker, were significantly associated with lower risk of cardiovascular disease (−4.5% risk for 10% higher paraoxonase,
P
<0.003; −5.3% risk for 10% higher 2,3 dinor‐8
iso
prostaglandin F
2α
,
P
=0.0092). In contrast, the oxidative markers myeloperoxidase and F
2α
isoprostanes were not significantly associated with cardiovascular disease after adjustment for glycated hemoblobin. There were no significant differences between
DCCT
intensive and conventional treatment groups in the change in all biomarkers across time segments.
Conclusions
Heightened antioxidant activity (rather than diminished oxidative stress markers) is associated with lower cardiovascular disease risk in type 1 diabetes mellitus, but these biomarkers did not change over time with intensification of glycemic control.
Clinical Trial Registration
URL
:
https://www.clinicaltrials.gov
. Unique identifiers:
NCT
00360815 and
NCT
00360893.
Collapse
Affiliation(s)
- W.H. Wilson Tang
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH
| | - Paula McGee
- The Biostatistics Center, George Washington University, Rockville, MD
| | - John M. Lachin
- The Biostatistics Center, George Washington University, Rockville, MD
| | - Daniel Y. Li
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
| | | | - Stanley L. Hazen
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
155
|
Abstract
Introduction Electronic healthcare records from the UK are accessible to researchers via several platforms, but these platforms typically include data from a limited subset of health and care services. The Kent Integrated Dataset (KID) provides insight into system-wide health and care utilisation for the whole population of Kent and Medway. Processes The KID uses pseudonymisation-at-source to link patient-level records from services including general practices, hospitals, community health services and social care. Data is refreshed monthly and processes to monitor data quality have been developed. Data contents For each episode of care, the KID includes date of the episode, the type of service accessed, the cost of the episode and clinical information such as the health condition being treated and results of diagnostic tests. The dataset also includes contextual information such as the neighbourhood deprivation. Conclusions The KID is a unique and rich dataset available to researchers who are investigating a broad range of public health questions. It provides system-level insight into patient journeys and care utilisation and supports commissioning based on patient needs
Collapse
Affiliation(s)
- D Lewer
- Institute of Health Informatics, University College London, 222 Euston Road, London, NW1 2DA, UK
| | - T Bourne
- Public Health Department, Kent County Council, Sessions House, County Road, Maidstone ME14 1QX
| | - A George
- Public Health Department, Kent County Council, Sessions House, County Road, Maidstone ME14 1QX
| | - G Abi-Aad
- Public Health Department, Kent County Council, Sessions House, County Road, Maidstone ME14 1QX
| | - C Taylor
- Public Health Department, Kent County Council, Sessions House, County Road, Maidstone ME14 1QX
| | - J George
- Institute of Health Informatics, University College London, 222 Euston Road, London, NW1 2DA, UK
| |
Collapse
|
156
|
Berks M, Dinsdale G, Murray A, Moore T, Manning J, Taylor C, Herrick AL. Automated structure and flow measurement - a promising tool in nailfold capillaroscopy. Microvasc Res 2018; 118:173-177. [PMID: 29605552 PMCID: PMC5956308 DOI: 10.1016/j.mvr.2018.03.016] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2017] [Revised: 03/08/2018] [Accepted: 03/28/2018] [Indexed: 11/30/2022]
Abstract
OBJECTIVES Despite increasing interest in nailfold capillaroscopy, objective measures of capillary structure and blood flow have been little studied. We aimed to test the hypothesis that structural measurements, capillary flow, and a combined measure have the predictive power to separate patients with systemic sclerosis (SSc) from those with primary Raynaud's phenomenon (PRP) and healthy controls (HC). METHODS 50 patients with SSc, 12 with PRP, and 50 HC were imaged using a novel capillaroscopy system that generates high-quality nailfold images and provides fully-automated measurements of capillary structure and blood flow (capillary density, mean width, maximum width, shape score, derangement and mean flow velocity). Population statistics summarise the differences between the three groups. Areas under ROC curves (AZ) were used to measure classification accuracy when assigning individuals to SSc and HC/PRP groups. RESULTS Statistically significant differences in group means were found between patients with SSc and both HC and patients with PRP, for all measurements, e.g. mean width (μm) ± SE: 15.0 ± 0.71, 12.7 ± 0.74 and 11.8 ± 0.23 for SSc, PRP and HC respectively. Combining the five structural measurements gave better classification (AZ = 0.919 ± 0.026) than the best single measurement (mean width, AZ = 0.874 ± 0.043), whilst adding flow further improved classification (AZ = 0.930 ± 0.024). CONCLUSIONS Structural and blood flow measurements are both able to distinguish patients with SSc from those with PRP/HC. Importantly, these hold promise as clinical trial outcome measures for treatments aimed at improving finger blood flow or microvascular remodelling.
Collapse
Affiliation(s)
- Michael Berks
- Centre for Imaging Sciences, Division of Informatics, Imaging & Data Sciences, The University of Manchester, Manchester, UK
| | - Graham Dinsdale
- Division of Musculoskeletal & Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - Andrea Murray
- Division of Musculoskeletal & Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
| | - Tonia Moore
- Salford Royal NHS Foundation Trust, Salford, UK
| | | | - Chris Taylor
- Centre for Imaging Sciences, Division of Informatics, Imaging & Data Sciences, The University of Manchester, Manchester, UK
| | - Ariane L Herrick
- Division of Musculoskeletal & Dermatological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
| |
Collapse
|
157
|
Shrestha P, Asher J, Shrestha S, Jenner S, Wilson C, Taylor C, Rewcastle T, Handerson D, Wilson M, Rix D, Talbot D. Survival of Arteriovenous Fistula for Dialysis at Different Centers in the North of England. J Vasc Access 2018. [DOI: 10.1177/112972980700800403] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Background Renal failure patients rely on their vascular access for hemodialysis. Surgery for construction of arteriovenous fistulae is provided by a range of specialists. The aim of this review was to assess the survival of arteriovenous fistulae for hemodialysis patients in different centers of Northern England. Methods Data was collected on 473 hemodialysis patients in the North of England. Risk factors for failure were determined for each patient (age, sex, diabetes), together with their current mode of dialysis and history of surgical access procedures. This was expressed against their duration of dialysis. The dialysis units were then compared for fistula survival using the Kaplan Meier method. Results 68.3% (323) patients were dialysed through via arteriovenous fistulae and 31.7% (150) via neck line. Overall fistula survival rates were 85.1% at 1 year, 82.5% at 2 years and 72.7% at 3 years. The best 1 year survival was 91.6% and worst 76.1%. These were 74.4% and 53.1% at 5 years and 74.4% and 29.5% at 10 years; these differences were highly statistically significant (p=0.0033). Conclusion Though graft survival is affected by many things, surgical training in access surgery is not mandatory and a review of surgical practice is urgently needed.
Collapse
Affiliation(s)
- P.C. Shrestha
- Renal and Liver Transplant Unit, Freeman Hospital, Newcastle upon Tyne - UK
| | - J. Asher
- Renal and Liver Transplant Unit, Freeman Hospital, Newcastle upon Tyne - UK
| | - S.M. Shrestha
- Renal and Liver Transplant Unit, Freeman Hospital, Newcastle upon Tyne - UK
| | - S. Jenner
- Renal Unit, Cumberland Infirmary, Carlisle - UK
| | - C. Wilson
- Dialysis Unit, Royal Victoria Infirmary, Newcastle upon Tyne - UK
| | - C. Taylor
- Dialysis Unit, Freeman Hospital, Newcastle upon Tyne - UK
| | - T. Rewcastle
- Dialysis Unit, The James Cook University Hospital, Middlesbrough - UK
| | - D. Handerson
- Darlington Dialysis Unit, Darlington Memorial Hospital, Darlington - UK
| | - M. Wilson
- Renal Unit, Sunderland Royal Hospital, Sunderland - UK
| | - D. Rix
- Renal and Liver Transplant Unit, Freeman Hospital, Newcastle upon Tyne - UK
| | - D. Talbot
- Renal and Liver Transplant Unit, Freeman Hospital, Newcastle upon Tyne - UK
| |
Collapse
|
158
|
Taylor C, Eyre S, Hinks A, Thomson W, Yarwood A, Martin P, Duffus K, McGovern A. 13. Identifying distal interactions between RUNX1 and JIA associated SNP by Chromosome Conformation Capture. Rheumatology (Oxford) 2018. [DOI: 10.1093/rheumatology/kex390.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
159
|
Doran-Browne N, Wootton M, Taylor C, Eckard R. Offsets required to reduce the carbon balance of sheep and beef farms through carbon sequestration in trees and soils. Anim Prod Sci 2018. [DOI: 10.1071/an16438] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The sustainability of farming is important to ensure that natural resources remain available into the future. Ruminant livestock production generates more greenhouse gas emissions than other types of agricultural production and most livestock mitigation options to date have a modest greenhouse gas reduction potential (<20%). Trees and soils, by comparison, can sequester large amounts of carbon depending on the availability of land. Previous studies on carbon neutral livestock production have shown that farms with a stocking rate of 8 dry sheep equivalents (DSE)/ha can be carbon neutral or carbon positive by sequestering more carbon than is emitted from the farm. However, the carbon offsets required by farms with higher stocking rates (>20 DSE/ha) has yet to be studied in Australia. The challenge is to sequester enough carbon to offset the higher level of emissions that these higher stocked farms produce. This study calculated the carbon balance of wool, prime lamb and beef enterprises using a range of stocking rates (6–22 DSE/ha) and levels of tree cover in two agroecological zones. Emissions from livestock, energy and transport were offset by the carbon sequestered in trees and soils. Additionally, the carbon balance was calculated of a case study, Jigsaw Farms, an intensive sheep and beef farm in south-eastern Australia. The methods used to calculate emissions and carbon stocks were from the Australian National Greenhouse Gas Inventory. The majority of stocking rates were carbon positive over a 25-year period when 20% of the sheep or beef enterprises were covered with trees. This study demonstrated that substantial reductions can be made in greenhouse gas emissions through the use of carbon sequestration, particularly in trees. The results showed that from 2000 to 2014 Jigsaw Farms reduced its emissions by 48% by sequestering carbon in trees and soil. The analysis of different stocking rates and tree cover provides an important reference point for farmers, researchers and policy analysts to estimate the carbon balance of wool, prime lamb and beef enterprises based on stocking rate and the area of tree cover.
Collapse
|
160
|
Dolly S, Brandão M, Taylor C, Gunapala R, Myerson J, Waddell T, Popat S, Bhosle J, O’Brien M. The impact of the UK Government ‘two week rule’ (TWR) on lung cancer stage and 5-year survival – a decade of experience from the Royal Marsden Hospital (RMH). Lung Cancer 2018. [DOI: 10.1016/s0169-5002(18)30070-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
161
|
Scovelle A, Oldenburg B, Thomas E, Taylor C, Hare D, Toukhsati S, Oldroyd J, Rangani W, Dheerasinghe A, O’Neil A. Sex-Specific Differences in Percutaneous Coronary Intervention Outcomes Following Acute Coronary Syndrome. Heart Lung Circ 2018. [DOI: 10.1016/j.hlc.2018.06.865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
162
|
Regan SP, Goncharov VN, Sangster TC, Campbell EM, Betti R, Anderson KS, Bernat T, Bose A, Boehly TR, Bonino MJ, Cao D, Chapman R, Collins TJB, Craxton RS, Davis AK, Delettrez JA, Edgell DH, Epstein R, Farrell M, Forrest CJ, Frenje JA, Froula DH, Johnson MG, Gibson C, Glebov VY, Greenwood A, Harding DR, Hohenberger M, Hu SX, Huang H, Hund J, Igumenshchev IV, Jacobs-Perkins DW, Janezic RT, Karasik M, Keck RL, Kelly JH, Kessler TJ, Knauer JP, Kosc TZ, Loucks SJ, Marozas JA, Marshall FJ, McCrory RL, McKenty PW, Meyerhofer DD, Michel DT, Myatt JF, Obenschain SP, Petrasso RD, Petta N, Radha PB, Rosenberg MJ, Schmitt AJ, Schmitt MJ, Schoff M, Seka W, Shmayda WT, Shoup MJ, Shvydky A, Solodov AA, Stoeckl C, Sweet W, Taylor C, Taylor R, Theobald W, Ulreich J, Wittman MD, Woo KM, Zuegel JD. The National Direct-Drive Program: OMEGA to the National Ignition Facility. Fusion Science and Technology 2017. [DOI: 10.1080/15361055.2017.1397487] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- S. P. Regan
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - V. N. Goncharov
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - T. C. Sangster
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - E. M. Campbell
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - R. Betti
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - K. S. Anderson
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - T. Bernat
- Schafer Corporation, Livermore, California
| | - A. Bose
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - T. R. Boehly
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - M. J. Bonino
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - D. Cao
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - R. Chapman
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - T. J. B. Collins
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - R. S. Craxton
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - A. K. Davis
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - J. A. Delettrez
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - D. H. Edgell
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - R. Epstein
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | | | - C. J. Forrest
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - J. A. Frenje
- Massachusetts Institute of Technology, Plasma Science and Fusion Center, Cambridge, Massachusetts
| | - D. H. Froula
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - M. Gatu Johnson
- Massachusetts Institute of Technology, Plasma Science and Fusion Center, Cambridge, Massachusetts
| | - C. Gibson
- General Atomics, San Diego, California
| | - V. Yu. Glebov
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | | | - D. R. Harding
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - M. Hohenberger
- Lawrence Livermore National Laboratory, Livermore, California
| | - S. X. Hu
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - H. Huang
- General Atomics, San Diego, California
| | - J. Hund
- Schafer Corporation, Livermore, California
| | - I. V. Igumenshchev
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | | | - R. T. Janezic
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - M. Karasik
- Naval Research Laboratory, Washington, District of Columbia
| | - R. L. Keck
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - J. H. Kelly
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - T. J. Kessler
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - J. P. Knauer
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - T. Z. Kosc
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - S. J. Loucks
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - J. A. Marozas
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - F. J. Marshall
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - R. L. McCrory
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - P. W. McKenty
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | | | - D. T. Michel
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - J. F. Myatt
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | | | - R. D. Petrasso
- Massachusetts Institute of Technology, Plasma Science and Fusion Center, Cambridge, Massachusetts
| | - N. Petta
- Schafer Corporation, Livermore, California
| | - P. B. Radha
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - M. J. Rosenberg
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - A. J. Schmitt
- Naval Research Laboratory, Washington, District of Columbia
| | - M. J. Schmitt
- Los Alamos National Laboratory, Los Alamos, New Mexico
| | - M. Schoff
- General Atomics, San Diego, California
| | - W. Seka
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - W. T. Shmayda
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - M. J. Shoup
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - A. Shvydky
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - A. A. Solodov
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - C. Stoeckl
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - W. Sweet
- General Atomics, San Diego, California
| | - C. Taylor
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - R. Taylor
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - W. Theobald
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - J. Ulreich
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - M. D. Wittman
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - K. M. Woo
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| | - J. D. Zuegel
- University of Rochester, Laboratory for Laser Energetics, Rochester, New York
| |
Collapse
|
163
|
Harding DR, Ulreich J, Wittman MD, Chapman R, Taylor C, Taylor R, Redden NP, Lambropoulos JC, Gram RQ, Bonino MJ, Turner DW. Requirements and Capabilities for Fielding Cryogenic DT-Containing Fill-Tube Targets for Direct-Drive Experiments on OMEGA. Fusion Science and Technology 2017. [DOI: 10.1080/15361055.2017.1374812] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- D. R. Harding
- University of Rochester, Laboratory for Laser Energetics, 250 East River Road., Rochester, New York 14623-1299
| | - J. Ulreich
- University of Rochester, Laboratory for Laser Energetics, 250 East River Road., Rochester, New York 14623-1299
| | - M. D. Wittman
- University of Rochester, Laboratory for Laser Energetics, 250 East River Road., Rochester, New York 14623-1299
| | - R. Chapman
- University of Rochester, Laboratory for Laser Energetics, 250 East River Road., Rochester, New York 14623-1299
| | - C. Taylor
- University of Rochester, Laboratory for Laser Energetics, 250 East River Road., Rochester, New York 14623-1299
| | - R. Taylor
- University of Rochester, Laboratory for Laser Energetics, 250 East River Road., Rochester, New York 14623-1299
| | - N. P. Redden
- University of Rochester, Laboratory for Laser Energetics, 250 East River Road., Rochester, New York 14623-1299
| | - J. C. Lambropoulos
- University of Rochester, Laboratory for Laser Energetics, 250 East River Road., Rochester, New York 14623-1299
| | - R. Q. Gram
- University of Rochester, Laboratory for Laser Energetics, 250 East River Road., Rochester, New York 14623-1299
| | - M. J. Bonino
- University of Rochester, Laboratory for Laser Energetics, 250 East River Road., Rochester, New York 14623-1299
| | - D. W. Turner
- University of Rochester, Laboratory for Laser Energetics, 250 East River Road., Rochester, New York 14623-1299
| |
Collapse
|
164
|
Islam S, Taylor C, Hayter J. Does your face fit? Facial morphology as a predictor of success in UK & US general elections. Br J Oral Maxillofac Surg 2017. [DOI: 10.1016/j.bjoms.2017.08.189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
165
|
Robinson S, Harris A, Atkinson S, Atterbury C, Bolton-Maggs P, Elliott C, Hawkins T, Hazra E, Howell C, New H, Shackleton T, Shreeve K, Taylor C. The administration of blood components: a British Society for Haematology Guideline. Transfus Med 2017; 28:3-21. [PMID: 29110357 DOI: 10.1111/tme.12481] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2017] [Revised: 09/04/2017] [Accepted: 09/16/2017] [Indexed: 01/02/2023]
Affiliation(s)
- S Robinson
- Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK
| | - A Harris
- Diagnostic and Therapeutic Services, NHS Blood and Transplant (NHSBT), Birmingham, UK
| | - S Atkinson
- Department Anaesthesia, Belfast Health and Social Care Trust, Chair of Northern Ireland Transfusion Committee, Northern, Ireland
| | - C Atterbury
- Department of Haematology, The Queen Elizabeth Hospital Kings Lynn NHS Foundation Trust, King's Lyn, UK
| | - P Bolton-Maggs
- Serious Hazards of Transfusion (SHOT) Office, NHSBT, Manchester, UK
| | - C Elliott
- Transfusion, South Tees Hospitals NHS Trust, Middlesbrough, UK
| | - T Hawkins
- Department of Haematology, Royal Berkshire NHS Foundation Trust, Reading, Berkshire, UK
| | - E Hazra
- NHS National Services Scotland, Scottish National Blood Transfusion Service - Better Blood Transfusion, United Kingdom of Great Britain & Northern Ireland
| | - C Howell
- Diagnostic and Therapeutic Services, NHSBT, Bristol, UK
| | - H New
- Products, NHSBT, London, UK
| | - T Shackleton
- Department of Haematology, Alder Hey Hospital Children's NHS Foundation Trust, Liverpool, UK
| | - K Shreeve
- Better Blood Transfusion Team, Welsh Blood Service, Pencoed, UK
| | - C Taylor
- Haematology, Dudley Group of Hospitals NHS Foundation Trust, Dudley, UK
| |
Collapse
|
166
|
Salem R, Taylor C, Wright T, Holman A, Wallace M, Ball T, Hawken R. Trauma Triage in the English Riviera. Int J Surg 2017. [DOI: 10.1016/j.ijsu.2017.08.435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
167
|
Wang B, Abbott L, Childs K, Taylor C, Agarwal K, Cormack I, Miquel R, Suddle A. Dolutegravir-induced liver injury leading to sub-acute liver failure requiring transplantation: a case report and review of literature. Int J STD AIDS 2017; 29:414-417. [PMID: 29059031 DOI: 10.1177/0956462417734099] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
A patient with human immunodeficiency virus-1 infection presented with sub-acute liver failure, temporally related to commencement of an antiretroviral therapy regimen containing dolutegravir (Triumeq). The patient was not a carrier of HLA-B5701, and abacavir hypersensitivity was unlikely. We believe this is the first report of severe dolutegravir-related hepatotoxicity resulting in sub-acute liver failure and transplantation and highlights a potential need for closer monitoring after drug initiation.
Collapse
Affiliation(s)
- Bo Wang
- 1 Institute of Liver Studies, King's College Hospital, London, UK
| | - Laura Abbott
- 2 Department of Genitourinary Medicine and HIV, 156767 Croydon University Hospital , Croydon, UK
| | - Kate Childs
- 1 Institute of Liver Studies, King's College Hospital, London, UK.,3 Department of Sexual Health and HIV, The Caldecot Centre, King's College Hospital, London, UK
| | - Chris Taylor
- 3 Department of Sexual Health and HIV, The Caldecot Centre, King's College Hospital, London, UK
| | - Kosh Agarwal
- 1 Institute of Liver Studies, King's College Hospital, London, UK
| | - Ian Cormack
- 2 Department of Genitourinary Medicine and HIV, 156767 Croydon University Hospital , Croydon, UK
| | - Rosa Miquel
- 4 Institute of Liver Studies, Liver Histopathology Laboratory, King?s College Hospital, London, UK
| | - Abid Suddle
- 1 Institute of Liver Studies, King's College Hospital, London, UK
| |
Collapse
|
168
|
Hughes P, Smith L, Horn F, Biancardi A, Collier G, Stewart N, Norquay G, Rao M, Aldag I, Taylor C, Marshall H, Wild J. Ventilation heterogeneity assessed in patients with mild cystic fibrosis and asthma using Hyperpolarised gas MRI histogram analysis. Imaging 2017. [DOI: 10.1183/1393003.congress-2017.oa4645] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
|
169
|
Shapiro A, Trujillo E, Taylor C, Mills J, Johnson S, Spees C. Malnutrition Screening: An Underutilized Screening Tool for Outpatient Oncology Patients. J Acad Nutr Diet 2017. [DOI: 10.1016/j.jand.2017.06.127] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
170
|
Gallacher C, Thomas R, Lord R, Kalin RM, Taylor C. Comprehensive database of Manufactured Gas Plant tars. Part C. Heterocyclic and hydroxylated polycyclic aromatic hydrocarbons. Rapid Commun Mass Spectrom 2017; 31:1250-1260. [PMID: 28514513 DOI: 10.1002/rcm.7904] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Revised: 05/04/2017] [Accepted: 05/06/2017] [Indexed: 06/07/2023]
Abstract
RATIONALE Coal tars are a mixture of organic and inorganic compounds that were by-products from the manufactured gas and coke making industries. The tar compositions varied depending on many factors such as the temperature of production and the type of retort used. For this reason a comprehensive database of the compounds found in different tar types is of value to understand both how their compositions differ and what potential chemical hazards are present. This study focuses on the heterocyclic and hydroxylated compounds present in a database produced from 16 different tars from five different production processes. METHODS Samples of coal tar were extracted using accelerated solvent extraction (ASE) and derivatized post-extraction using N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% trimethylchlorosilane (TMCS). The derivatized samples were analysed using two-dimensional gas chromatography combined with time-of-flight mass spectrometry (GCxGC/TOFMS). RESULTS A total of 865 heterocyclic compounds and 359 hydroxylated polycyclic aromatic hydrocarbons (PAHs) were detected in 16 tar samples produced by five different processes. The contents of both heterocyclic and hydroxylated PAHs varied greatly with the production process used, with the heterocyclic compounds giving information about the feedstock used. Of the 359 hydroxylated PAHs detected the majority would not have been be detected without the use of derivatization. CONCLUSIONS Coal tars produced using different production processes and feedstocks yielded tars with significantly different heterocyclic and hydroxylated contents. The concentrations of the individual heterocyclic compounds varied greatly even within the different production processes and provided information about the feedstock used to produce the tars. The hydroxylated PAH content of the samples provided important analytical information that would otherwise not have been obtained without the use of derivatization and GCxGC/TOFMS.
Collapse
Affiliation(s)
- Christopher Gallacher
- Department of Civil and Environmental Engineering, University of Strathclyde, 75 Montrose St., Glasgow, G1 1XJ, UK
| | - Russell Thomas
- WSP/Parsons Brinckerhoff, Kings Orchard, 1 Queen St, Bristol, BS2 0HQ, UK
| | - Richard Lord
- Department of Civil and Environmental Engineering, University of Strathclyde, 75 Montrose St., Glasgow, G1 1XJ, UK
| | - Robert M Kalin
- Department of Civil and Environmental Engineering, University of Strathclyde, 75 Montrose St., Glasgow, G1 1XJ, UK
| | - Chris Taylor
- National Grid Property, Warwick Technology Park, Warwick, CV34 6DA, UK
| |
Collapse
|
171
|
Gallacher C, Thomas R, Lord R, Kalin RM, Taylor C. Comprehensive database of Manufactured Gas Plant tars. Part B. Aliphatic and aromatic compounds. Rapid Commun Mass Spectrom 2017; 31:1239-1249. [PMID: 28494122 DOI: 10.1002/rcm.7900] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Revised: 03/30/2017] [Accepted: 05/06/2017] [Indexed: 05/20/2023]
Abstract
RATIONALE Coal tars are a mixture of organic and inorganic compounds that were produced as a by-product from the manufactured gas and coke making industries. The composition of the tar produced varies depending on many factors; these include the temperature of production and the type of retort used. As different production processes produce different tars, a comprehensive database of the compounds present within coal tars from different production processes is a valuable resource. Such a database would help to understand how their chemical properties differ and what hazards the compounds present within these tars might pose. This study focuses on the aliphatic and aromatic compounds present in a database of 16 different tars from five different production processes. METHODS Samples of coal tar were extracted using accelerated solvent extraction (ASE) and derivatised post-extraction using N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% trimethylchlorosilane (TMCS). The derivatised samples were analysed using two-dimensional gas chromatography combined with time-of-flight mass spectrometry (GCxGC/TOFMS). RESULTS A total of 198 individual aliphatic and 951 individual aromatic compounds were detected within 16 tar samples produced by five different production processes. The polycyclic aromatic hydrocarbon (PAH) content of coal tars varies greatly depending on the production process used to obtain the tars and this is clearly demonstrated within the results. The aliphatic composition of the tars provided an important piece of analytical information that would have otherwise been missed with the detection of petrogenic compounds such as alkyl cyclohexanes. CONCLUSIONS The aromatic compositions of the tar samples varied greatly between the different production processes investigated and useful analytical information was obtained about the individual production process groups. Alkyl cyclohexanes were detected in all samples from sites known to operate Carbureted Water Gas plants and not detected in those that did not. This suggests that petrogenic material may be expected at many UK gaswork sites.
Collapse
Affiliation(s)
- Christopher Gallacher
- Department of Civil and Environmental Engineering, University of Strathclyde, 75 Montrose St., Glasgow, G1 1XJ, UK
| | - Russell Thomas
- WSP/Parsons Brinckerhoff, Kings Orchard, 1 Queen St, Bristol, BS2 0HQ, UK
| | - Richard Lord
- Department of Civil and Environmental Engineering, University of Strathclyde, 75 Montrose St., Glasgow, G1 1XJ, UK
| | - Robert M Kalin
- Department of Civil and Environmental Engineering, University of Strathclyde, 75 Montrose St., Glasgow, G1 1XJ, UK
| | - Chris Taylor
- National Grid Property, Warwick Technology Park, Warwick, CV34 6DA, UK
| |
Collapse
|
172
|
Gallacher C, Thomas R, Lord R, Kalin RM, Taylor C. Comprehensive database of Manufactured Gas Plant tars. Part A. Database. Rapid Commun Mass Spectrom 2017; 31:1231-1238. [PMID: 28488792 DOI: 10.1002/rcm.7901] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/05/2016] [Revised: 03/30/2017] [Accepted: 05/06/2017] [Indexed: 06/07/2023]
Abstract
RATIONALE Coal tars are a mixture of organic and inorganic compounds that were by-products from the manufactured gas and coke making industries. Different manufacturing processes have resulted in the production of distinctly different tar compositions. This study presents a comprehensive database of compounds produced using two-dimensional gas chromatography combined with time-of-flight mass spectrometry (GCxGC/TOFMS), analysing 16 tar samples produced by five distinct production processes. METHODS Samples of coal tar were extracted using accelerated solvent extraction (ASE) and derivatised post-extraction using N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% trimethylchlorosilane (TMCS). The derivatised samples were analysed using two-dimensional gas chromatography combined with time-of-flight mass spectrometry (GCxGC/TOFMS). RESULTS A total of 16 tar samples originating from five different production processes: Low Temperature Horizontal Retorts, Horizontal Retorts, Vertical Retorts, Carbureted Water Gas and Coke Ovens, were analysed. A total of 2369 unique compounds were detected with 948 aromatic compounds, 196 aliphatic compounds, 380 sulfur-containing compounds, 209 oxygen-containing compounds, 262 nitrogen-containing compounds and 15 mixed heterocycles. Derivatisation allowed the detection of 359 unique compounds, the majority in the form of hydroxylated polycyclic aromatic hydrocarbons, many of which would not have been detected without derivatisation. Of the 2369 unique compounds detected, 173 were found to be present within all samples. CONCLUSIONS A unique comprehensive database of compounds detected within 16 tar samples from five different production processes was produced. The 173 compounds identified within every sample may be of particular importance from a regulatory standpoint. This initial study indicates that different production processes produce tars with different chemical signatures and it can be further expanded upon by in-depth analysis of the different compound types. The number of compounds presented within this database clearly demonstrates the analytical power of GCxGC/TOFMS.
Collapse
Affiliation(s)
- Christopher Gallacher
- Department of Civil and Environmental Engineering, University of Strathclyde, 75 Montrose St., Glasgow, G1 1XJ, UK
| | - Russell Thomas
- WSP/Parsons Brinckerhoff, Kings Orchard, 1 Queen St, Bristol, BS2 0HQ, UK
| | - Richard Lord
- Department of Civil and Environmental Engineering, University of Strathclyde, 75 Montrose St., Glasgow, G1 1XJ, UK
| | - Robert M Kalin
- Department of Civil and Environmental Engineering, University of Strathclyde, 75 Montrose St., Glasgow, G1 1XJ, UK
| | - Chris Taylor
- National Grid Property, Warwick Technology Park, Warwick, CV34 6DA, UK
| |
Collapse
|
173
|
Mannion S, Lee P, Taylor C. Cold Case Files: 15 years on, did patient controlled analgesia mask acute compartment syndrome? Ir Med J 2017; 110:625. [PMID: 29169007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Affiliation(s)
- S Mannion
- Department of Anaesthesiology, South Infirmary Victoria University Hospital, Cork, Ireland
| | - P Lee
- Department of Anaesthesia & Intensive Care, Cork University Hospital, Cork, Ireland
| | - C Taylor
- Department of Orthopaedics and Trauma, Cork University Hospital & South Infirmary Victoria University Hospital, Cork, Ireland
| |
Collapse
|
174
|
Hamidi HR, Bandla S, Khazanov N, William P, Bonevich N, Zurenko C, Anstead S, Taylor C, Richmonds R, Galimberti D, Kopp K, Cyanam D, Hogan M, Mittal V, Sadis S. Abstract 3811: Defining the relevant genome in solid tumors. Cancer Res 2017. [DOI: 10.1158/1538-7445.am2017-3811] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Decades of cancer research including comprehensive molecular profiling combined with the development of a broad array of targeted therapies have created the opportunity to transform cancer care by implementing precision oncology based approaches. An important element of this system is the widespread availability of robust and cost-effective multi-variate profiling methods to characterize relevant cancer associated molecular alterations in the future. Current commercially available multi-variate profiling methods vary dramatically with regard to the number of cancer genes that are interrogated. Given that many large scale and detailed molecular profiling studies have been completed, the landscape of somatic alterations in solid tumors is reasonably well-known. Furthermore, the specific gene variants that are relevant to application of targeted therapies are also a matter of record. Therefore, we set out to define the number of relevant cancer genes for precision oncology research based on the currently available empirical evidence. To define recurrent somatic alterations in solid tumors, we created a compendium of variant calls from > 15,000 exomes, defined focal amplifications and deletions from > 30,000 arrays, and defined recurrent fusions from several thousand RNAseq profiles. Statistical approaches were implemented to define genes containing recurrent missense mutations (i.e., hotspots), enriched in truncating mutations or subject to recurrent copy number gain/loss or translocation. This gene set was then used to comprehensively search approved cancer drug labels, clinical practice guidelines, and clinical trials to identify records containing published evidence that specific recurrent somatic gene variants were used as part of the indication statement of an approved targeted therapy, were recommended for testing as part of clinical practice for therapeutic decisions, or were used as enrollment criteria in clinical trials. The relevant cancer genome thus defined consists of < 100 genes. These results suggest that targeted multi-variate profiling approaches may be sufficient to support precision oncology goals in the future.
Citation Format: Habib R. Hamidi, Santoshi Bandla, Nick Khazanov, Paul William, Nikki Bonevich, Chris Zurenko, Sarah Anstead, Chris Taylor, Reuban Richmonds, David Galimberti, Ken Kopp, Dinesh Cyanam, Michael Hogan, Vinay Mittal, Seth Sadis. Defining the relevant genome in solid tumors [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 3811. doi:10.1158/1538-7445.AM2017-3811
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | - Ken Kopp
- Thermo Fisher Scientific, Ann Arbor, MI
| | | | | | | | | |
Collapse
|
175
|
|
176
|
Bikdeli B, Heggodu Devappa S, Beare C, Taylor C. Improving quality of medical admission clerking and validation of medical assessment proforma, complete audit cycle 1. Intern Med J 2017. [DOI: 10.1111/imj.3_13461] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- B Bikdeli
- Northern Adelaide Local Health Network; Adelaide South Australia Australia
- University of Adelaide; Discipline of Medicine; Adelaide South Australia Australia
| | - S Heggodu Devappa
- Northern Adelaide Local Health Network; Adelaide South Australia Australia
| | - C Beare
- Northern Adelaide Local Health Network; Adelaide South Australia Australia
| | - C Taylor
- Northern Adelaide Local Health Network; Adelaide South Australia Australia
| |
Collapse
|
177
|
Whitfield SJC, Taylor C, Risdall JE, Griffiths GD, Jones JTA, Williamson ED, Rijpkema S, Saraiva L, Vessillier S, Green AC, Carter AJ. Interference of the T Cell and Antigen-Presenting Cell Costimulatory Pathway Using CTLA4-Ig (Abatacept) Prevents Staphylococcal Enterotoxin B Pathology. J Immunol 2017; 198:3989-3998. [PMID: 28320831 DOI: 10.4049/jimmunol.1601525] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/06/2016] [Accepted: 02/11/2017] [Indexed: 12/20/2022]
Abstract
Staphylococcal enterotoxin B (SEB) is a bacterial superantigen that binds the receptors in the APC/T cell synapse and causes increased proliferation of T cells and a cytokine storm syndrome in vivo. Exposure to the toxin can be lethal and cause significant pathology in humans. The lack of effective therapies for SEB exposure remains an area of concern, particularly in scenarios of acute mass casualties. We hypothesized that blockade of the T cell costimulatory signal by the CTLA4-Ig synthetic protein (abatacept) could prevent SEB-dependent pathology. In this article, we demonstrate mice treated with a single dose of abatacept 8 h post SEB exposure had reduced pathology compared with control SEB-exposed mice. SEB-exposed mice showed significant reductions in body weight between days 4 and 9, whereas mice exposed to SEB and also treated with abatacept showed no weight loss for the duration of the study, suggesting therapeutic mitigation of SEB-induced morbidity. Histopathology and magnetic resonance imaging demonstrated that SEB mediated lung damage and edema, which were absent after treatment with abatacept. Analysis of plasma and lung tissues from SEB-exposed mice treated with abatacept demonstrated significantly lower levels of IL-6 and IFN-γ (p < 0.0001), which is likely to have resulted in less pathology. In addition, exposure of human and mouse PBMCs to SEB in vitro showed a significant reduction in levels of IL-2 (p < 0.0001) after treatment with abatacept, indicating that T cell proliferation is the main target for intervention. Our findings demonstrate that abatacept is a robust and potentially credible drug to prevent toxic effects from SEB exposure.
Collapse
Affiliation(s)
- Sarah J C Whitfield
- Department of Biomedical Sciences, Defence Science and Technology Laboratory, Salisbury, Wiltshire SP4 0JQ, United Kingdom;
| | - Chris Taylor
- Department of Biomedical Sciences, Defence Science and Technology Laboratory, Salisbury, Wiltshire SP4 0JQ, United Kingdom
| | - Jane E Risdall
- Department of Biomedical Sciences, Defence Science and Technology Laboratory, Salisbury, Wiltshire SP4 0JQ, United Kingdom.,Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, United Kingdom
| | - Gareth D Griffiths
- Department of Biomedical Sciences, Defence Science and Technology Laboratory, Salisbury, Wiltshire SP4 0JQ, United Kingdom
| | - James T A Jones
- Department of Biomedical Sciences, Defence Science and Technology Laboratory, Salisbury, Wiltshire SP4 0JQ, United Kingdom
| | - E Diane Williamson
- Department of Biomedical Sciences, Defence Science and Technology Laboratory, Salisbury, Wiltshire SP4 0JQ, United Kingdom
| | - Sjoerd Rijpkema
- Division of Bacteriology, National Institute for Biological Standards and Control, Potters Bar EN6 3QG, United Kingdom
| | - Luisa Saraiva
- Division of Biotherapeutics, National Institute for Biological Standards and Control, Potters Bar EN6 3QG, United Kingdom; and
| | - Sandrine Vessillier
- Division of Biotherapeutics, National Institute for Biological Standards and Control, Potters Bar EN6 3QG, United Kingdom; and
| | - A Christopher Green
- Department of Biomedical Sciences, Defence Science and Technology Laboratory, Salisbury, Wiltshire SP4 0JQ, United Kingdom
| | - Alun J Carter
- Department of Biomedical Sciences, Defence Science and Technology Laboratory, Salisbury, Wiltshire SP4 0JQ, United Kingdom.,Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110
| |
Collapse
|
178
|
Reyes S, Anklam T, Babineau D, Becnel J, Davis R, Dunne M, Farmer J, Flowers D, Kramer K, Martinez-Frias J, Miles R, Taylor C. LIFE Tritium Processing: A Sustainable Solution for Closing the Fusion Fuel Cycle. Fusion Science and Technology 2017. [DOI: 10.13182/fst12-529] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- S. Reyes
- Lawrence Livermore National Laboratory, Livermore, CA USA
| | - T. Anklam
- Lawrence Livermore National Laboratory, Livermore, CA USA
| | - D. Babineau
- Savannah River National Laboratory, Aiken, SC, USA
| | - J. Becnel
- Savannah River National Laboratory, Aiken, SC, USA
| | - R. Davis
- Savannah River Site, Aiken, SC, USA
| | - M. Dunne
- Lawrence Livermore National Laboratory, Livermore, CA USA
| | - J. Farmer
- Lawrence Livermore National Laboratory, Livermore, CA USA
| | - D. Flowers
- Lawrence Livermore National Laboratory, Livermore, CA USA
| | - K. Kramer
- Lawrence Livermore National Laboratory, Livermore, CA USA
| | | | - R. Miles
- Lawrence Livermore National Laboratory, Livermore, CA USA
| | - C. Taylor
- Los Alamos National Laboratory, Los Alamos, NM, USA
| |
Collapse
|
179
|
Candfield S, Samuel MI, Ritchie D, McDonald C, Brady M, Taylor C. Use and acceptability of salivary hepatitis C virus testing in an English Young Offender Institution. Int J STD AIDS 2017. [PMID: 28632479 DOI: 10.1177/0956462417696214] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
People held in prison are at a high risk of having hepatitis C virus (HCV) and there is a public health drive in the UK to increase HCV testing in prisons and Young Offender Institutions (YOIs), with opt-out testing. There is an oral antibody test for HCV; this project aims to determine its acceptability in an English YOI setting. This project offered HCV oral point-of-care testing (POCT) using the OraQuick® test to 107 male young offenders attending a sexual health service at an English YOI, monitoring HCV positivity and evaluating acceptability. It also investigated young offenders' histories of sexually transmitted infections (STIs) and drug use. Mean age was 19.1 years. A total of 80.4% reported lifetime drug use and 0.9% reported lifetime drug injection. A total of 19.6% reported previous STIs. One patient (0.9%) was positive for HCV on OraQuick® testing. All patients found the POCT acceptable and one stated he would have refused a fingerprick test had it been the only test available for HCV testing. Salivary rapid HCV testing is acceptable among English YOI inmates. It is not as sensitive or specific as standard HCV tests and is more expensive. In our cohort, HCV positivity was low.
Collapse
Affiliation(s)
- Sophie Candfield
- 1 Central and North West London NHS Foundation Trust, The Mortimer Market Centre, London, UK
| | | | - David Ritchie
- 3 Terrence Higgins Trust, London, UK.,4 Guys and St Thomas NHS Foundation Trust, The Burrell Street Sexual Health Centre, London, UK
| | - Candice McDonald
- 2 The Caldecot Centre, Kings College Hospital NHS Foundation Trust, London, UK
| | - Michael Brady
- 2 The Caldecot Centre, Kings College Hospital NHS Foundation Trust, London, UK.,3 Terrence Higgins Trust, London, UK
| | - Chris Taylor
- 2 The Caldecot Centre, Kings College Hospital NHS Foundation Trust, London, UK
| |
Collapse
|
180
|
Taylor C, Cadenhead N, Lindenmayer DB, Wintle BA. Improving the Design of a Conservation Reserve for a Critically Endangered Species. PLoS One 2017; 12:e0169629. [PMID: 28121984 PMCID: PMC5266334 DOI: 10.1371/journal.pone.0169629] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2016] [Accepted: 12/20/2016] [Indexed: 12/03/2022] Open
Abstract
Setting aside protected areas is a key strategy for tackling biodiversity loss. Reserve effectiveness depends on the extent to which protected areas capture both known occurrences and areas likely to support the species. We assessed the effectiveness of the existing reserve network for Leadbeater's Possum (Gymnobelideus leadbeateri) and other forest-dependent species, and compared the existing reserve system to a set of plausible reserve expansion options based on area targets implied in a recent Population Viability Analysis (PVA). The existing Leadbeater's Reserve and surrounding reserve system captured 7.6% and 29.6% of cumulative habitat suitability, respectively, across the landscape. Expanded reserve scenarios captured 34% to 62% of cumulative habitat suitability. We found acute trade-offs between conserving Leadbeater's Possum habitat and conserving habitat of other forest-dependent species. Our analysis provides a template for systematically expanding and evaluating reserve expansion options in terms of trade-offs between priority species' needs.
Collapse
Affiliation(s)
- Chris Taylor
- Melbourne Sustainable Society Institute, University of Melbourne, Parkville, Victoria, Australia
| | - Natasha Cadenhead
- School of Biosciences, University of Melbourne, Parkville, Victoria, Australia
| | - David B. Lindenmayer
- Fenner School of Environment and Society, The Australian National University, Canberra, Australian Capital Territory, Australia
| | - Brendan A. Wintle
- School of Biosciences, University of Melbourne, Parkville, Victoria, Australia
| |
Collapse
|
181
|
Taylor C, Tuddenham N, Egan C. Increased dorsiflexion a risk factor for lower limb injury in junior elite Australian football players. J Sci Med Sport 2017. [DOI: 10.1016/j.jsams.2017.01.164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
182
|
Khalid T, Mortimer H, Taylor C. 148: Pleural effusion management in a District General Hospital (DGH): Respiratory Registrar experience. Lung Cancer 2017. [DOI: 10.1016/s0169-5002(17)30198-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
183
|
Moses R, Taylor C, Wood S, Vyas A. P191 Reducing the carbon footprint in a regional long term ventilation service with the use of remote monitoring. Thorax 2016. [DOI: 10.1136/thoraxjnl-2016-209333.334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
184
|
Nilson PM, Ehrne F, Mileham C, Mastrosimone D, Jungquist RK, Taylor C, Stillman CR, Ivancic ST, Boni R, Hassett J, Lonobile DJ, Kidder RW, Shoup MJ, Solodov AA, Stoeckl C, Theobald W, Froula DH, Hill KW, Gao L, Bitter M, Efthimion P, Meyerhofer DD. A high-resolving-power x-ray spectrometer for the OMEGA EP Laser (invited). Rev Sci Instrum 2016; 87:11D504. [PMID: 27910626 DOI: 10.1063/1.4961076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
A high-resolving-power x-ray spectrometer has been developed for the OMEGA EP Laser System based on a spherically bent Si [220] crystal with a radius of curvature of 330 mm and a Spectral Instruments (SI) 800 Series charge-coupled device. The instrument measures time-integrated x-ray emission spectra in the 7.97- to 8.11-keV range, centered on the Cu Kα1 line. To demonstrate the performance of the spectrometer under high-power conditions, Kα1,2 emission spectra were measured from Cu foils irradiated by the OMEGA EP laser with 100-J, 1-ps pulses at focused intensities above 1018 W/cm2. The ultimate goal is to couple the spectrometer to a picosecond x-ray streak camera and measure temperature-equilibration dynamics inside rapidly heated materials. The plan for these ultrafast streaked x-ray spectroscopy studies is discussed.
Collapse
Affiliation(s)
- P M Nilson
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - F Ehrne
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - C Mileham
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - D Mastrosimone
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - R K Jungquist
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - C Taylor
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - C R Stillman
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - S T Ivancic
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - R Boni
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - J Hassett
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - D J Lonobile
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - R W Kidder
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - M J Shoup
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - A A Solodov
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - C Stoeckl
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - W Theobald
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - D H Froula
- Laboratory for Laser Energetics, University of Rochester, Rochester, New York 14623-1299, USA
| | - K W Hill
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08543-0451, USA
| | - L Gao
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08543-0451, USA
| | - M Bitter
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08543-0451, USA
| | - P Efthimion
- Princeton Plasma Physics Laboratory, Princeton, New Jersey 08543-0451, USA
| | - D D Meyerhofer
- Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA
| |
Collapse
|
185
|
Taylor C, Pedroso J, Brotherton J, Volker KW. Laparoscopic Management of Parasitic Myoma. J Minim Invasive Gynecol 2016. [DOI: 10.1016/j.jmig.2016.08.558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
186
|
Johnston T, Brown S, Kaliarntas K, Taylor C. NON-CONTACT INJURY INCIDENCE AND WARM UP OBSERVATION IN HOCKEY IN SCOTLAND. Br J Sports Med 2016. [DOI: 10.1136/bjsports-2016-096952.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
187
|
Taylor C, Sigala W, Pedroso J, Gutierrez M, Vennart M, Volker KW. Laparoscopic Aspiration of an Ovarian Cyst in Pregnancy. J Minim Invasive Gynecol 2016. [DOI: 10.1016/j.jmig.2016.08.492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
188
|
Stockwell E, Taylor C, Pedroso J, Volker KW. Laparoscopic Management of Endometrioma with Incidental Inguinal Hernia. J Minim Invasive Gynecol 2016. [DOI: 10.1016/j.jmig.2016.08.559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
189
|
Targher G, Dauriz M, Laroche C, Temporelli PL, Hassanein M, Seferovic PM, Drozdz J, Ferrari R, Anker S, Coats A, Filippatos G, Crespo‐Leiro MG, Mebazaa A, Piepoli MF, Maggioni AP, Tavazzi L, Crespo‐Leiro M, Anker S, Coats A, Ferrari R, Filippatos G, Maggioni A, Mebazaa A, Piepoli M, Amir O, Chioncel O, Dahlström U, Jimenez JD, Drozdz J, Erglis A, Fazlibegovic E, Fonseca C, Fruhwald F, Gatzov P, Goncalvesova E, Hassanein M, Hradec J, Kavoliuniene A, Lainscak M, Logeart D, Merkely B, Metra M, Otljanska M, Seferovic P, Kostovska ES, Temizhan A, Tousoulis D, Andarala M, Ferreira T, Fiorucci E, Gracia G, Laroche C, Pommier C, Taylor C, Cuculici A, Gaulhofer C, Casado EP, Szymczyk E, Ramani F, Mulak G, Schou IL, Semenka J, Stojkovic J, Mehanna R, Mizarienne V, Auer J, Ablasser K, Fruhwald F, Dolze T, Brandner K, Gstrein S, Poelzl G, Moertl D, Reiter S, Podczeck‐Schweighofer A, Muslibegovic A, Vasilj M, Fazlibegovic E, Cesko M, Zelenika D, Palic B, Pravdic D, Cuk D, Vitlianova K, Katova T, Velikov T, Kurteva T, Gatzov P, Kamenova D, Antova M, Sirakova V, Krejci J, Mikolaskova M, Spinar J, Krupicka J, Malek F, Hegarova M, Lazarova M, Monhart Z, Hassanein M, Sobhy M, El Messiry F, El Shazly A, Elrakshy Y, Youssef A, Moneim A, Noamany M, Reda A, Dayem TA, Farag N, Halawa SI, Hamid MA, Said K, Saleh A, Ebeid H, Hanna R, Aziz R, Louis O, Enen M, Ibrahim B, Nasr G, Elbahry A, Sobhy H, Ashmawy M, Gouda M, Aboleineen W, Bernard Y, Luporsi P, Meneveau N, Pillot M, Morel M, Seronde M, Schiele F, Briand F, Delahaye F, Damy T, Eicher J, Groote P, Fertin M, Lamblin N, Isnard R, Lefol C, Thevenin S, Hagege A, Jondeau G, Logeart D, Le Marcis V, Ly J, Coisne D, Lequeux B, Le Moal V, Mascle S, Lotton P, Behar N, Donal E, Thebault C, Ridard C, Reynaud A, Basquin A, Bauer F, Codjia R, Galinier M, Tourikis P, Stavroula M, Tousoulis D, Stefanadis C, Chrysohoou C, Kotrogiannis I, Matzaraki V, Dimitroula T, Karavidas A, Tsitsinakis G, Kapelios C, Nanas J, Kampouri H, Nana E, Kaldara E, Eugenidou A, Vardas P, Saloustros I, Patrianakos A, Tsaknakis T, Evangelou S, Nikoloulis N, Tziourganou H, Tsaroucha A, Papadopoulou A, Douras A, Polgar L, Merkely B, Kosztin A, Nyolczas N, Nagy AC, Halmosi R, Elber J, Alony I, Shotan A, Fuhrmann AV, Amir O, Romano S, Marcon S, Penco M, Di Mauro M, Lemme E, Carubelli V, Rovetta R, Metra M, Bulgari M, Quinzani F, Lombardi C, Bosi S, Schiavina G, Squeri A, Barbieri A, Di Tano G, Pirelli S, Ferrari R, Fucili A, Passero T, Musio S, Di Biase M, Correale M, Salvemini G, Brognoli S, Zanelli E, Giordano A, Agostoni P, Italiano G, Salvioni E, Copelli S, Modena M, Reggianini L, Valenti C, Olaru A, Bandino S, Deidda M, Mercuro G, Dessalvi CC, Marino P, Di Ruocco M, Sartori C, Piccinino C, Parrinello G, Licata G, Torres D, Giambanco S, Busalacchi S, Arrotti S, Novo S, Inciardi R, Pieri P, Chirco P, Galifi MA, Teresi G, Buccheri D, Minacapelli A, Veniani M, Frisinghelli A, Priori S, Cattaneo S, Opasich C, Gualco A, Pagliaro M, Mancone M, Fedele F, Cinque A, Vellini M, Scarfo I, Romeo F, Ferraiuolo F, Sergi D, Anselmi M, Melandri F, Leci E, Iori E, Bovolo V, Pidello S, Frea S, Bergerone S, Botta M, Canavosio F, Gaita F, Merlo M, Cinquetti M, Sinagra G, Ramani F, Fabris E, Stolfo D, Artico J, Miani D, Fresco C, Daneluzzi C, Proclemer A, Cicoira M, Zanolla L, Marchese G, Torelli F, Vassanelli C, Voronina N, Erglis A, Tamakauskas V, Smalinskas V, Karaliute R, Petraskiene I, Kazakauskaite E, Rumbinaite E, Kavoliuniene A, Vysniauskas V, Brazyte‐Ramanauskiene R, Petraskiene D, Stankala S, Switala P, Juszczyk Z, Sinkiewicz W, Gilewski W, Pietrzak J, Orzel T, Kasztelowicz P, Kardaszewicz P, Lazorko‐Piega M, Gabryel J, Mosakowska K, Bellwon J, Rynkiewicz A, Raczak G, Lewicka E, Dabrowska‐Kugacka A, Bartkowiak R, Sosnowska‐Pasiarska B, Wozakowska‐Kaplon B, Krzeminski A, Zabojszcz M, Mirek‐Bryniarska E, Grzegorzko A, Bury K, Nessler J, Zalewski J, Furman A, Broncel M, Poliwczak A, Bala A, Zycinski P, Rudzinska M, Jankowski L, Kasprzak J, Michalak L, Soska KW, Drozdz J, Huziuk I, Retwinski A, Flis P, Weglarz J, Bodys A, Grajek S, Kaluzna‐Oleksy M, Straburzynska‐Migaj E, Dankowski R, Szymanowska K, Grabia J, Szyszka A, Nowicka A, Samcik M, Wolniewicz L, Baczynska K, Komorowska K, Poprawa I, Komorowska E, Sajnaga D, Zolbach A, Dudzik‐Plocica A, Abdulkarim A, Lauko‐Rachocka A, Kaminski L, Kostka A, Cichy A, Ruszkowski P, Splawski M, Fitas G, Szymczyk A, Serwicka A, Fiega A, Zysko D, Krysiak W, Szabowski S, Skorek E, Pruszczyk P, Bienias P, Ciurzynski M, Welnicki M, Mamcarz A, Folga A, Zielinski T, Rywik T, Leszek P, Sobieszczanska‐Malek M, Piotrowska M, Kozar‐Kaminska K, Komuda K, Wisniewska J, Tarnowska A, Balsam P, Marchel M, Opolski G, Kaplon‐Cieslicka A, Gil R, Mozenska O, Byczkowska K, Gil K, Pawlak A, Michalek A, Krzesinski P, Piotrowicz K, Uzieblo‐Zyczkowska B, Stanczyk A, Skrobowski A, Ponikowski P, Jankowska E, Rozentryt P, Polonski L, Gadula‐Gacek E, Nowalany‐Kozielska E, Kuczaj A, Kalarus Z, Szulik M, Przybylska K, Klys J, Prokop‐Lewicka G, Kleinrok A, Aguiar CT, Ventosa A, Pereira S, Faria R, Chin J, De Jesus I, Santos R, Silva P, Moreno N, Queirós C, Lourenço C, Pereira A, Castro A, Andrade A, Guimaraes TO, Martins S, Placido R, Lima G, Brito D, Francisco A, Cardiga R, Proenca M, Araujo I, Marques F, Fonseca C, Moura B, Leite S, Campelo M, Silva‐Cardoso J, Rodrigues J, Rangel I, Martins E, Correia AS, Peres M, Marta L, Silva GF, Severino D, Durao D, Leao S, Magalhaes P, Moreira I, Cordeiro AF, Ferreira C, Araujo C, Ferreira A, Baptista A, Radoi M, Bicescu G, Vinereanu D, Sinescu C, Macarie C, Popescu R, Daha I, Dan G, Stanescu C, Dan A, Craiu E, Nechita E, Aursulesei V, Christodorescu R, Otasevic P, Seferovic P, Simeunovic D, Ristic A, Celic V, Pavlovic‐Kleut M, Lazic JS, Stojcevski B, Pencic B, Stevanovic A, Andric A, Iric‐Cupic V, Jovic M, Davidovic G, Milanov S, Mitic V, Atanaskovic V, Antic S, Pavlovic M, Stanojevic D, Stoickov V, Ilic S, Ilic MD, Petrovic D, Stojsic S, Kecojevic S, Dodic S, Adic NC, Cankovic M, Stojiljkovic J, Mihajlovic B, Radin A, Radovanovic S, Krotin M, Klabnik A, Goncalvesova E, Pernicky M, Murin J, Kovar F, Kmec J, Semjanova H, Strasek M, Iskra MS, Ravnikar T, Suligoj NC, Komel J, Fras Z, Jug B, Glavic T, Losic R, Bombek M, Krajnc I, Krunic B, Horvat S, Kovac D, Rajtman D, Cencic V, Letonja M, Winkler R, Valentincic M, Melihen‐Bartolic C, Bartolic A, Vrckovnik MP, Kladnik M, Pusnik CS, Marolt A, Klen J, Drnovsek B, Leskovar B, Anguita MF, Page JG, Martinez FS, Andres J, Genis A, Mirabet S, Mendez A, Garcia‐Cosio L, Roig E, Leon V, Gonzalez‐Costello J, Muntane G, Garay A, Alcade‐Martinez V, Fernandez SL, Rivera‐Lopez R, Puga‐Martinez M, Fernandez‐Alvarez M, Serrano‐Martinez J, Crespo‐Leiro M, Grille‐Cancela Z, Marzoa‐Rivas R, Blanco‐Canosa P, Paniagua‐Martin M, Barge‐Caballero E, Cerdena IL, Baldomero IFH, Padron AL, Rosillo SO, Gonzalez‐Gallarza RD, Montanes OS, Manjavacas AI, Conde AC, Araujo A, Soria T, Garcia‐Pavia P, Gomez‐Bueno M, Cobo‐Marcos M, Alonso‐Pulpon L, Cubero JS, Sayago I, Gonzalez‐Segovia A, Briceno A, Subias PE, Hernandez MV, Cano MR, Sanchez MG, Jimenez JD, Garrido‐Lestache EB, Pinilla JG, Villa BG, Sahuquillo A, Marques RB, Calvo FT, Perez‐Martinez M, Gracia‐Rodenas M, Garrido‐Bravo IP, Pastor‐Perez F, Pascual‐Figal D, Molina BD, Orus J, Gonzalo FE, Bertomeu V, Valero R, Martinez‐Abellan R, Quiles J, Rodrigez‐Ortega J, Mateo I, ElAmrani A, Fernandez‐Vivancos C, Valero DB, Almenar‐Bonet L, Sanchez‐Lazaro I, Marques‐Sule E, Facila‐Rubio L, Perez‐Silvestre J, Garcia‐Gonzalez P, Ridocci‐Soriano F, Garcia‐Escriva D, Pellicer‐Cabo A, Fuente Galan L, Diaz JL, Platero AR, Arias J, Blasco‐Peiro T, Julve MS, Sanchez‐Insa E, Aured‐Guallar C, Portoles‐Ocampo A, Melin M, Hägglund E, Stenberg A, Lindahl I, Asserlund B, Olsson L, Dahlström U, Afzelius M, Karlström P, Tengvall L, Wiklund P, Olsson B, Kalayci S, Temizhan A, Cavusoglu Y, Gencer E, Yilmaz M, Gunes H. In‐hospital and 1‐year mortality associated with diabetes in patients with acute heart failure: results from the
ESC‐HFA
Heart Failure Long‐Term Registry. Eur J Heart Fail 2016; 19:54-65. [DOI: 10.1002/ejhf.679] [Citation(s) in RCA: 105] [Impact Index Per Article: 13.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/10/2016] [Revised: 08/24/2016] [Accepted: 09/20/2016] [Indexed: 12/28/2022] Open
Affiliation(s)
- Giovanni Targher
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine University and Azienda Ospedaliera Universitaria Integrata of Verona Verona Italy
| | - Marco Dauriz
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine University and Azienda Ospedaliera Universitaria Integrata of Verona Verona Italy
| | - Cécile Laroche
- EURObservational Research Programme European Society of Cardiology Sophia‐Antipolis France
| | | | | | | | | | - Roberto Ferrari
- Department of Cardiology and LTTA Centre, University Hospital of Ferrara and Maria Cecilia Hospital, GVM Care & Research E.S: Health Science Foundation Cotignola Italy
| | - Stephan Anker
- Innovative Clinical Trials, Department of Cardiology & Pneumology University Medical Center Göttingen (UMG) Göttingen Germany
| | - Andrew Coats
- Monash University Australia and University of Warwick Coventry UK
| | | | - Maria G. Crespo‐Leiro
- Unidad de Insuficiencia Cardiaca Avanzada y Trasplante Cardiaco, Complexo Hospitalario Universitario A Coruna CHUAC La Coruna Spain
| | - Alexandre Mebazaa
- Inserm 942, Hôpital Lariboisière Université Paris Diderot Paris France
| | - Massimo F. Piepoli
- Department of Cardiology Polichirurgico Hospital G. da Saliceto Piacenza Italy
| | - Aldo Pietro Maggioni
- EURObservational Research Programme European Society of Cardiology Sophia‐Antipolis France
- ANMCO Research Center Florence Italy
| | - Luigi Tavazzi
- Maria Cecilia Hospital, GVM Care & Research E.S. Health Science Foundation Cotignola Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
190
|
Vohra RS, Pasquali S, Kirkham AJ, Marriott P, Johnstone M, Spreadborough P, Alderson D, Griffiths EA, Fenwick S, Elmasry M, Nunes Q, Kennedy D, Basit Khan R, Khan MAS, Magee CJ, Jones SM, Mason D, Parappally CP, Mathur P, Saunders M, Jamel S, Ul Haque S, Zafar S, Shiwani MH, Samuel N, Dar F, Jackson A, Lovett B, Dindyal S, Winter H, Fletcher T, Rahman S, Wheatley K, Nieto T, Ayaani S, Youssef H, Nijjar RS, Watkin H, Naumann D, Emeshi S, Sarmah PB, Lee K, Joji N, Heath J, Teasdale RL, Weerasinghe C, Needham PJ, Welbourn H, Forster L, Finch D, Blazeby JM, Robb W, McNair AGK, Hrycaiczuk A, Charalabopoulos A, Kadirkamanathan S, Tang CB, Jayanthi NVG, Noor N, Dobbins B, Cockbain AJ, Nilsen-Nunn A, Siqueira J, Pellen M, Cowley JB, Ho WM, Miu V, White TJ, Hodgkins KA, Kinghorn A, Tutton MG, Al-Abed YA, Menzies D, Ahmad A, Reed J, Khan S, Monk D, Vitone LJ, Murtaza G, Joel A, Brennan S, Shier D, Zhang C, Yoganathan T, Robinson SJ, McCallum IJD, Jones MJ, Elsayed M, Tuck L, Wayman J, Carney K, Aroori S, Hosie KB, Kimble A, Bunting DM, Fawole AS, Basheer M, Dave RV, Sarveswaran J, Jones E, Kendal C, Tilston MP, Gough M, Wallace T, Singh S, Downing J, Mockford KA, Issa E, Shah N, Chauhan N, Wilson TR, Forouzanfar A, Wild JRL, Nofal E, Bunnell C, Madbak K, Rao STV, Devoto L, Siddiqi N, Khawaja Z, Hewes JC, Gould L, Chambers A, Urriza Rodriguez D, Sen G, Robinson S, Carney K, Bartlett F, Rae DM, Stevenson TEJ, Sarvananthan K, Dwerryhouse SJ, Higgs SM, Old OJ, Hardy TJ, Shah R, Hornby ST, Keogh K, Frank L, Al-Akash M, Upchurch EA, Frame RJ, Hughes M, Jelley C, Weaver S, Roy S, Sillo TO, Galanopoulos G, Cuming T, Cunha P, Tayeh S, Kaptanis S, Heshaishi M, Eisawi A, Abayomi M, Ngu WS, Fleming K, Singh Bajwa D, Chitre V, Aryal K, Ferris P, Silva M, Lammy S, Mohamed S, Khawaja A, Hussain A, Ghazanfar MA, Bellini MI, Ebdewi H, Elshaer M, Gravante G, Drake B, Ogedegbe A, Mukherjee D, Arhi C, Giwa Nusrat Iqbal L, Watson NF, Kumar Aggarwal S, Orchard P, Villatoro E, Willson PD, Wa K, Mok J, Woodman T, Deguara J, Garcea G, Babu BI, Dennison AR, Malde D, Lloyd D, Satheesan S, Al-Taan O, Boddy A, Slavin JP, Jones RP, Ballance L, Gerakopoulos S, Jambulingam P, Mansour S, Sakai N, Acharya V, Sadat MM, Karim L, Larkin D, Amin K, Khan A, Law J, Jamdar S, Smith SR, Sampat K, M O'shea K, Manu M, Asprou FM, Malik NS, Chang J, Johnstone M, Lewis M, Roberts GP, Karavadra B, Photi E, Hewes J, Gould L, Chambers A, Rodriguez D, O'Reilly DA, Rate AJ, Sekhar H, Henderson LT, Starmer BZ, Coe PO, Tolofari S, Barrie J, Bashir G, Sloane J, Madanipour S, Halkias C, Trevatt AEJ, Borowski DW, Hornsby J, Courtney MJ, Virupaksha S, Seymour K, Robinson S, Hawkins H, Bawa S, Gallagher PV, Reid A, Wood P, Finch JG, Parmar J, Stirland E, Gardner-Thorpe J, Al-Muhktar A, Peterson M, Majeed A, Bajwa FM, Martin J, Choy A, Tsang A, Pore N, Andrew DR, Al-Khyatt W, Taylor C, Bhandari S, Chambers A, Subramanium D, Toh SKC, Carter NC, Mercer SJ, Knight B, Tate S, Pearce B, Wainwright D, Vijay V, Alagaratnam S, Sinha S, Khan S, El-Hasani SS, Hussain AA, Bhattacharya V, Kansal N, Fasih T, Jackson C, Siddiqui MN, Chishti IA, Fordham IJ, Siddiqui Z, Bausbacher H, Geogloma I, Gurung K, Tsavellas G, Basynat P, Kiran Shrestha A, Basu S, Chhabra Mohan Harilingam A, Rabie M, Akhtar M, Kumar P, Jafferbhoy SF, Hussain N, Raza S, Haque M, Alam I, Aseem R, Patel S, Asad M, Booth MI, Ball WR, Wood CPJ, Pinho-Gomes AC, Kausar A, Rami Obeidallah M, Varghase J, Lodhia J, Bradley D, Rengifo C, Lindsay D, Gopalswamy S, Finlay I, Wardle S, Bullen N, Iftikhar SY, Awan A, Ahmed J, Leeder P, Fusai G, Bond-Smith G, Psica A, Puri Y, Hou D, Noble F, Szentpali K, Broadhurst J, Date R, Hossack MR, Li Goh Y, Turner P, Shetty V, Riera M, Macano CAW, Sukha A, Preston SR, Hoban JR, Puntis DJ, Williams SV, Krysztopik R, Kynaston J, Batt J, Doe M, Goscimski A, Jones GH, Smith SR, Hall C, Carty N, Ahmed J, Panteleimonitis S, Gunasekera RT, Sheel ARG, Lennon H, Hindley C, Reddy M, Kenny R, Elkheir N, McGlone ER, Rajaganeshan R, Hancorn K, Hargreaves A, Prasad R, Longbotham DA, Vijayanand D, Wijetunga I, Ziprin P, Nicolay CR, Yeldham G, Read E, Gossage JA, Rolph RC, Ebied H, Phull M, Khan MA, Popplewell M, Kyriakidis D, Hussain A, Henley N, Packer JR, Derbyshire L, Porter J, Appleton S, Farouk M, Basra M, Jennings NA, Ali S, Kanakala V, Ali H, Lane R, Dickson-Lowe R, Zarsadias P, Mirza D, Puig S, Al Amari K, Vijayan D, Sutcliffe R, Marudanayagam R, Hamady Z, Prasad AR, Patel A, Durkin D, Kaur P, Bowen L, Byrne JP, Pearson KL, Delisle TG, Davies J, Tomlinson MA, Johnpulle MA, Slawinski C, Macdonald A, Nicholson J, Newton K, Mbuvi J, Farooq A, Sidhartha Mothe B, Zafrani Z, Brett D, Francombe J, Spreadborough P, Barnes J, Cheung M, Al-Bahrani AZ, Preziosi G, Urbonas T, Alberts J, Mallik M, Patel K, Segaran A, Doulias T, Sufi PA, Yao C, Pollock S, Manzelli A, Wajed S, Kourkulos M, Pezzuto R, Wadley M, Hamilton E, Jaunoo S, Padwick R, Sayegh M, Newton RC, Hebbar M, Farag SF, Spearman J, Hamdan MF, D'Costa C, Blane C, Giles M, Peter MB, Hirst NA, Hossain T, Pannu A, El-Dhuwaib Y, Morrison TEM, Taylor GW, Thompson RLE, McCune K, Loughlin P, Lawther R, Byrnes CK, Simpson DJ, Mawhinney A, Warren C, McKay D, McIlmunn C, Martin S, MacArtney M, Diamond T, Davey P, Jones C, Clements JM, Digney R, Chan WM, McCain S, Gull S, Janeczko A, Dorrian E, Harris A, Dawson S, Johnston D, McAree B, Ghareeb E, Thomas G, Connelly M, McKenzie S, Cieplucha K, Spence G, Campbell W, Hooks G, Bradley N, Hill ADK, Cassidy JT, Boland M, Burke P, Nally DM, Hill ADK, Khogali E, Shabo W, Iskandar E, McEntee GP, O'Neill MA, Peirce C, Lyons EM, O'Sullivan AW, Thakkar R, Carroll P, Ivanovski I, Balfe P, Lee M, Winter DC, Kelly ME, Hoti E, Maguire D, Karunakaran P, Geoghegan JG, Martin ST, McDermott F, Cross KS, Cooke F, Zeeshan S, Murphy JO, Mealy K, Mohan HM, Nedujchelyn Y, Fahad Ullah M, Ahmed I, Giovinazzo F, Milburn J, Prince S, Brooke E, Buchan J, Khalil AM, Vaughan EM, Ramage MI, Aldridge RC, Gibson S, Nicholson GA, Vass DG, Grant AJ, Holroyd DJ, Jones MA, Sutton CMLR, O'Dwyer P, Nilsson F, Weber B, Williamson TK, Lalla K, Bryant A, Carter CR, Forrest CR, Hunter DI, Nassar AH, Orizu MN, Knight K, Qandeel H, Suttie S, Belding R, McClarey A, Boyd AT, Guthrie GJK, Lim PJ, Luhmann A, Watson AJM, Richards CH, Nicol L, Madurska M, Harrison E, Boyce KM, Roebuck A, Ferguson G, Pati P, Wilson MSJ, Dalgaty F, Fothergill L, Driscoll PJ, Mozolowski KL, Banwell V, Bennett SP, Rogers PN, Skelly BL, Rutherford CL, Mirza AK, Lazim T, Lim HCC, Duke D, Ahmed T, Beasley WD, Wilkinson MD, Maharaj G, Malcolm C, Brown TH, Shingler GM, Mowbray N, Radwan R, Morcous P, Wood S, Kadhim A, Stewart DJ, Baker AL, Tanner N, Shenoy H, Hafiz S, Marchi JA, Singh-Ranger D, Hisham E, Ainley P, O'Neill S, Terrace J, Napetti S, Hopwood B, Rhys T, Downing J, Kanavati O, Coats M, Aleksandrov D, Kallaway C, Yahya S, Weber B, Templeton A, Trotter M, Lo C, Dhillon A, Heywood N, Aawsaj Y, Hamdan A, Reece-Bolton O, McGuigan A, Shahin Y, Ali A, Luther A, Nicholson JA, Rajendran I, Boal M, Ritchie J. Population-based cohort study of variation in the use of emergency cholecystectomy for benign gallbladder diseases. Br J Surg 2016; 103:1716-1726. [PMID: 27748962 DOI: 10.1002/bjs.10288] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2016] [Revised: 06/21/2016] [Accepted: 07/06/2016] [Indexed: 01/05/2023]
Abstract
Abstract
Background
The aims of this prospective population-based cohort study were to identify the patient and hospital characteristics associated with emergency cholecystectomy, and the influences of these in determining variations between hospitals.
Methods
Data were collected for consecutive patients undergoing cholecystectomy in acute UK and Irish hospitals between 1 March and 1 May 2014. Potential explanatory variables influencing the performance of emergency cholecystectomy were analysed by means of multilevel, multivariable logistic regression modelling using a two-level hierarchical structure with patients (level 1) nested within hospitals (level 2).
Results
Data were collected on 4744 cholecystectomies from 165 hospitals. Increasing age, lower ASA fitness grade, biliary colic, the need for further imaging (magnetic retrograde cholangiopancreatography), endoscopic interventions (endoscopic retrograde cholangiopancreatography) and admission to a non-biliary centre significantly reduced the likelihood of an emergency cholecystectomy being performed. The multilevel model was used to calculate the probability of receiving an emergency cholecystectomy for a woman aged 40 years or over with an ASA grade of I or II and a BMI of at least 25·0 kg/m2, who presented with acute cholecystitis with an ultrasound scan showing a thick-walled gallbladder and a normal common bile duct. The mean predicted probability of receiving an emergency cholecystectomy was 0·52 (95 per cent c.i. 0·45 to 0·57). The predicted probabilities ranged from 0·02 to 0·95 across the 165 hospitals, demonstrating significant variation between hospitals.
Conclusion
Patients with similar characteristics presenting to different hospitals with acute gallbladder pathology do not receive comparable care.
Collapse
Affiliation(s)
| | - R S Vohra
- Trent Oesophago-Gastric Unit, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - S Pasquali
- Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy
| | - A J Kirkham
- Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
| | - P Marriott
- West Midlands Research Collaborative, Academic Department of Surgery, University of Birmingham, Birmingham, UK
| | - M Johnstone
- West Midlands Research Collaborative, Academic Department of Surgery, University of Birmingham, Birmingham, UK
| | - P Spreadborough
- West Midlands Research Collaborative, Academic Department of Surgery, University of Birmingham, Birmingham, UK
| | - D Alderson
- Academic Department of Surgery, University of Birmingham, Birmingham, UK
| | - E A Griffiths
- Department of Upper Gastrointestinal Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | - S Fenwick
- Aintree University Hospital NHS Foundation Trust
| | - M Elmasry
- Aintree University Hospital NHS Foundation Trust
| | - Q Nunes
- Aintree University Hospital NHS Foundation Trust
| | - D Kennedy
- Aintree University Hospital NHS Foundation Trust
| | | | | | | | | | - D Mason
- Wirral University Teaching Hospital
| | | | | | | | - S Jamel
- Barnet and Chase Farm Hospital
| | | | - S Zafar
- Barnet and Chase Farm Hospital
| | | | - N Samuel
- Barnsley District General Hospital
| | - F Dar
- Barnsley District General Hospital
| | | | | | | | | | | | | | - K Wheatley
- Sandwell and West Birmingham Hospitals NHS Trust
| | - T Nieto
- Sandwell and West Birmingham Hospitals NHS Trust
| | - S Ayaani
- Sandwell and West Birmingham Hospitals NHS Trust
| | - H Youssef
- Heart of England Foundation NHS Trust
| | | | - H Watkin
- Heart of England Foundation NHS Trust
| | - D Naumann
- Heart of England Foundation NHS Trust
| | - S Emeshi
- Heart of England Foundation NHS Trust
| | | | - K Lee
- Heart of England Foundation NHS Trust
| | - N Joji
- Heart of England Foundation NHS Trust
| | - J Heath
- Blackpool Teaching Hospitals NHS Foundation Trust
| | - R L Teasdale
- Blackpool Teaching Hospitals NHS Foundation Trust
| | | | - P J Needham
- Bradford Teaching Hospitals NHS Foundation Trust
| | - H Welbourn
- Bradford Teaching Hospitals NHS Foundation Trust
| | - L Forster
- Bradford Teaching Hospitals NHS Foundation Trust
| | - D Finch
- Bradford Teaching Hospitals NHS Foundation Trust
| | | | - W Robb
- University Hospitals Bristol NHS Trust
| | | | | | | | | | | | | | | | - B Dobbins
- Calderdale and Huddersfield NHS Trust
| | | | | | | | - M Pellen
- Hull and East Yorkshire NHS Trust
| | | | - W-M Ho
- Hull and East Yorkshire NHS Trust
| | - V Miu
- Hull and East Yorkshire NHS Trust
| | - T J White
- Chesterfield Royal Hospital NHS Foundation Trust
| | - K A Hodgkins
- Chesterfield Royal Hospital NHS Foundation Trust
| | - A Kinghorn
- Chesterfield Royal Hospital NHS Foundation Trust
| | - M G Tutton
- Colchester Hospital University NHS Foundation Trust
| | - Y A Al-Abed
- Colchester Hospital University NHS Foundation Trust
| | - D Menzies
- Colchester Hospital University NHS Foundation Trust
| | - A Ahmad
- Colchester Hospital University NHS Foundation Trust
| | - J Reed
- Colchester Hospital University NHS Foundation Trust
| | - S Khan
- Colchester Hospital University NHS Foundation Trust
| | - D Monk
- Countess of Chester NHS Foundation Trust
| | - L J Vitone
- Countess of Chester NHS Foundation Trust
| | - G Murtaza
- Countess of Chester NHS Foundation Trust
| | - A Joel
- Countess of Chester NHS Foundation Trust
| | | | - D Shier
- Croydon Health Services NHS Trust
| | - C Zhang
- Croydon Health Services NHS Trust
| | | | | | | | - M J Jones
- North Cumbria University Hospitals Trust
| | - M Elsayed
- North Cumbria University Hospitals Trust
| | - L Tuck
- North Cumbria University Hospitals Trust
| | - J Wayman
- North Cumbria University Hospitals Trust
| | - K Carney
- North Cumbria University Hospitals Trust
| | | | | | | | | | | | | | | | | | | | | | - M P Tilston
- Northern Lincolnshire and Goole NHS Foundation Trust
| | - M Gough
- Northern Lincolnshire and Goole NHS Foundation Trust
| | - T Wallace
- Northern Lincolnshire and Goole NHS Foundation Trust
| | - S Singh
- Northern Lincolnshire and Goole NHS Foundation Trust
| | - J Downing
- Northern Lincolnshire and Goole NHS Foundation Trust
| | - K A Mockford
- Northern Lincolnshire and Goole NHS Foundation Trust
| | - E Issa
- Northern Lincolnshire and Goole NHS Foundation Trust
| | - N Shah
- Northern Lincolnshire and Goole NHS Foundation Trust
| | - N Chauhan
- Northern Lincolnshire and Goole NHS Foundation Trust
| | - T R Wilson
- Doncaster and Bassetlaw Hospitals NHS Foundation Trust
| | - A Forouzanfar
- Doncaster and Bassetlaw Hospitals NHS Foundation Trust
| | - J R L Wild
- Doncaster and Bassetlaw Hospitals NHS Foundation Trust
| | - E Nofal
- Doncaster and Bassetlaw Hospitals NHS Foundation Trust
| | - C Bunnell
- Doncaster and Bassetlaw Hospitals NHS Foundation Trust
| | - K Madbak
- Doncaster and Bassetlaw Hospitals NHS Foundation Trust
| | - S T V Rao
- Dorset County Hospital NHS Foundation Trust
| | - L Devoto
- Dorset County Hospital NHS Foundation Trust
| | - N Siddiqi
- Dorset County Hospital NHS Foundation Trust
| | - Z Khawaja
- Dorset County Hospital NHS Foundation Trust
| | | | | | | | | | | | | | | | | | - D M Rae
- Frimley Park Hospital NHS Trust
| | | | | | | | | | - O J Old
- Gloucestershire Hospitals NHS Trust
| | | | - R Shah
- Gloucestershire Hospitals NHS Trust
| | | | - K Keogh
- Gloucestershire Hospitals NHS Trust
| | - L Frank
- Gloucestershire Hospitals NHS Trust
| | - M Al-Akash
- Great Western Hospitals NHS Foundation Trust
| | | | - R J Frame
- Harrogate and District NHS Foundation Trust
| | - M Hughes
- Harrogate and District NHS Foundation Trust
| | - C Jelley
- Harrogate and District NHS Foundation Trust
| | | | | | | | | | - T Cuming
- Homerton University Hospital NHS Trust
| | - P Cunha
- Homerton University Hospital NHS Trust
| | - S Tayeh
- Homerton University Hospital NHS Trust
| | | | | | - A Eisawi
- Tees Hospitals NHS Foundation Trust
| | | | - W S Ngu
- Tees Hospitals NHS Foundation Trust
| | | | | | - V Chitre
- Paget University Hospitals NHS Foundation Trust
| | - K Aryal
- Paget University Hospitals NHS Foundation Trust
| | - P Ferris
- Paget University Hospitals NHS Foundation Trust
| | | | | | | | | | | | | | | | - H Ebdewi
- Kettering General Hospital NHS Foundation Trust
| | - M Elshaer
- Kettering General Hospital NHS Foundation Trust
| | - G Gravante
- Kettering General Hospital NHS Foundation Trust
| | - B Drake
- Kettering General Hospital NHS Foundation Trust
| | - A Ogedegbe
- Barking, Havering and Redbridge University Hospitals NHS Trust
| | - D Mukherjee
- Barking, Havering and Redbridge University Hospitals NHS Trust
| | - C Arhi
- Barking, Havering and Redbridge University Hospitals NHS Trust
| | | | | | | | | | | | | | - K Wa
- Kingston Hospital NHS Foundation Trust
| | - J Mok
- Kingston Hospital NHS Foundation Trust
| | - T Woodman
- Kingston Hospital NHS Foundation Trust
| | - J Deguara
- Kingston Hospital NHS Foundation Trust
| | - G Garcea
- University Hospitals of Leicester NHS Trust
| | - B I Babu
- University Hospitals of Leicester NHS Trust
| | | | - D Malde
- University Hospitals of Leicester NHS Trust
| | - D Lloyd
- University Hospitals of Leicester NHS Trust
| | | | - O Al-Taan
- University Hospitals of Leicester NHS Trust
| | - A Boddy
- University Hospitals of Leicester NHS Trust
| | - J P Slavin
- Leighton Hospital, Mid Cheshire Hospitals NHS Foundation Trust
| | - R P Jones
- Leighton Hospital, Mid Cheshire Hospitals NHS Foundation Trust
| | - L Ballance
- Leighton Hospital, Mid Cheshire Hospitals NHS Foundation Trust
| | - S Gerakopoulos
- Leighton Hospital, Mid Cheshire Hospitals NHS Foundation Trust
| | - P Jambulingam
- Luton and Dunstable University Hospital NHS Foundation Trust
| | - S Mansour
- Luton and Dunstable University Hospital NHS Foundation Trust
| | - N Sakai
- Luton and Dunstable University Hospital NHS Foundation Trust
| | - V Acharya
- Luton and Dunstable University Hospital NHS Foundation Trust
| | - M M Sadat
- Macclesfield District General Hospital
| | - L Karim
- Macclesfield District General Hospital
| | - D Larkin
- Macclesfield District General Hospital
| | - K Amin
- Macclesfield District General Hospital
| | - A Khan
- Central Manchester NHS Foundation Trust
| | - J Law
- Central Manchester NHS Foundation Trust
| | - S Jamdar
- Central Manchester NHS Foundation Trust
| | - S R Smith
- Central Manchester NHS Foundation Trust
| | - K Sampat
- Central Manchester NHS Foundation Trust
| | | | - M Manu
- Royal Wolverhampton Hospitals NHS Trust
| | | | - N S Malik
- Royal Wolverhampton Hospitals NHS Trust
| | - J Chang
- Royal Wolverhampton Hospitals NHS Trust
| | | | - M Lewis
- Norfolk and Norwich University Hospitals NHS Foundation Trust
| | - G P Roberts
- Norfolk and Norwich University Hospitals NHS Foundation Trust
| | - B Karavadra
- Norfolk and Norwich University Hospitals NHS Foundation Trust
| | - E Photi
- Norfolk and Norwich University Hospitals NHS Foundation Trust
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - J Hornsby
- North Tees and Hartlepool NHS Foundation Trust
| | | | | | - K Seymour
- Northumbria Healthcare NHS Foundation Trust
| | - S Robinson
- Northumbria Healthcare NHS Foundation Trust
| | - H Hawkins
- Northumbria Healthcare NHS Foundation Trust
| | - S Bawa
- Northumbria Healthcare NHS Foundation Trust
| | | | - A Reid
- Northumbria Healthcare NHS Foundation Trust
| | - P Wood
- Northumbria Healthcare NHS Foundation Trust
| | - J G Finch
- Northampton General Hospital NHS Trust
| | - J Parmar
- Northampton General Hospital NHS Trust
| | | | | | - A Al-Muhktar
- Sheffield Teaching Hospitals NHS Foundation Trust
| | - M Peterson
- Sheffield Teaching Hospitals NHS Foundation Trust
| | - A Majeed
- Sheffield Teaching Hospitals NHS Foundation Trust
| | | | | | - A Choy
- Peterborough City Hospital
| | | | - N Pore
- United Lincolnshire Hospitals NHS Trust
| | | | | | - C Taylor
- United Lincolnshire Hospitals NHS Trust
| | | | | | | | | | | | | | | | - S Tate
- Portsmouth Hospitals NHS Trust
| | | | | | - V Vijay
- The Princess Alexandra Hospital NHS Trust
| | | | - S Sinha
- The Princess Alexandra Hospital NHS Trust
| | - S Khan
- The Princess Alexandra Hospital NHS Trust
| | | | - A A Hussain
- King's College Hospital NHS Foundation Trust
| | | | - N Kansal
- Gateshead Health NHS Foundation Trust
| | - T Fasih
- Gateshead Health NHS Foundation Trust
| | - C Jackson
- Gateshead Health NHS Foundation Trust
| | | | | | | | | | | | | | - K Gurung
- Queen Elizabeth Hospital NHS Trust
| | - G Tsavellas
- East Kent Hospitals University NHS Foundation Trust
| | - P Basynat
- East Kent Hospitals University NHS Foundation Trust
| | | | - S Basu
- East Kent Hospitals University NHS Foundation Trust
| | | | - M Rabie
- East Kent Hospitals University NHS Foundation Trust
| | - M Akhtar
- East Kent Hospitals University NHS Foundation Trust
| | - P Kumar
- Burton Hospitals NHS Foundation Trust
| | | | - N Hussain
- Burton Hospitals NHS Foundation Trust
| | - S Raza
- Burton Hospitals NHS Foundation Trust
| | - M Haque
- Royal Albert Edward Infirmary, Wigan Wrightington and Leigh NHS Trust
| | - I Alam
- Royal Albert Edward Infirmary, Wigan Wrightington and Leigh NHS Trust
| | - R Aseem
- Royal Albert Edward Infirmary, Wigan Wrightington and Leigh NHS Trust
| | - S Patel
- Royal Albert Edward Infirmary, Wigan Wrightington and Leigh NHS Trust
| | - M Asad
- Royal Albert Edward Infirmary, Wigan Wrightington and Leigh NHS Trust
| | - M I Booth
- Royal Berkshire NHS Foundation Trust
| | - W R Ball
- Royal Berkshire NHS Foundation Trust
| | | | | | | | | | - J Varghase
- Royal Bolton Hospital NHS Foundation Trust
| | - J Lodhia
- Royal Bolton Hospital NHS Foundation Trust
| | - D Bradley
- Royal Bolton Hospital NHS Foundation Trust
| | - C Rengifo
- Royal Bolton Hospital NHS Foundation Trust
| | - D Lindsay
- Royal Bolton Hospital NHS Foundation Trust
| | | | | | | | | | | | - A Awan
- Royal Derby NHS Foundation Trust
| | - J Ahmed
- Royal Derby NHS Foundation Trust
| | - P Leeder
- Royal Derby NHS Foundation Trust
| | | | | | | | | | - D Hou
- Hampshire Hospital NHS Foundation Trust
| | - F Noble
- Hampshire Hospital NHS Foundation Trust
| | | | | | - R Date
- Lancashire Teaching Hospitals NHS Foundation Trust
| | - M R Hossack
- Lancashire Teaching Hospitals NHS Foundation Trust
| | - Y Li Goh
- Lancashire Teaching Hospitals NHS Foundation Trust
| | - P Turner
- Lancashire Teaching Hospitals NHS Foundation Trust
| | - V Shetty
- Lancashire Teaching Hospitals NHS Foundation Trust
| | | | | | | | - S R Preston
- Royal Surrey County Hospital NHS Foundation Trust
| | - J R Hoban
- Royal Surrey County Hospital NHS Foundation Trust
| | - D J Puntis
- Royal Surrey County Hospital NHS Foundation Trust
| | - S V Williams
- Royal Surrey County Hospital NHS Foundation Trust
| | | | | | - J Batt
- Royal United Hospital Bath NHS Trust
| | - M Doe
- Royal United Hospital Bath NHS Trust
| | | | | | | | - C Hall
- Salford Royal NHS Foundation Trust
| | - N Carty
- Salisbury Hospital Foundation Trust
| | - J Ahmed
- Salisbury Hospital Foundation Trust
| | | | | | | | - H Lennon
- Southport and Ormskirk Hospital NHS Trust
| | - C Hindley
- Southport and Ormskirk Hospital NHS Trust
| | - M Reddy
- St George's Healthcare NHS Trust
| | - R Kenny
- St George's Healthcare NHS Trust
| | | | | | | | - K Hancorn
- St Helens and Knowsley Teaching Hospitals NHS Trust
| | - A Hargreaves
- St Helens and Knowsley Teaching Hospitals NHS Trust
| | | | | | | | | | - P Ziprin
- Imperial College Healthcare NHS Trust
| | | | - G Yeldham
- Imperial College Healthcare NHS Trust
| | - E Read
- Imperial College Healthcare NHS Trust
| | | | | | | | | | - M A Khan
- Mid Staffordshire NHS Foundation Trust
| | | | | | - A Hussain
- Mid Staffordshire NHS Foundation Trust
| | | | | | | | | | | | | | | | | | - S Ali
- City Hospitals Sunderland NHS Foundation Trust
| | - V Kanakala
- City Hospitals Sunderland NHS Foundation Trust
| | - H Ali
- Tunbridge Wells and Maidstone NHS Trust
| | - R Lane
- Tunbridge Wells and Maidstone NHS Trust
| | | | | | - D Mirza
- University Hospital Birmingham NHS Foundation Trust
| | - S Puig
- University Hospital Birmingham NHS Foundation Trust
| | - K Al Amari
- University Hospital Birmingham NHS Foundation Trust
| | - D Vijayan
- University Hospital Birmingham NHS Foundation Trust
| | - R Sutcliffe
- University Hospital Birmingham NHS Foundation Trust
| | | | - Z Hamady
- University Hospital Coventry and Warwickshire NHS Trust
| | - A R Prasad
- University Hospital Coventry and Warwickshire NHS Trust
| | - A Patel
- University Hospital Coventry and Warwickshire NHS Trust
| | - D Durkin
- University Hospital of North Staffordshire NHS Trust
| | - P Kaur
- University Hospital of North Staffordshire NHS Trust
| | - L Bowen
- University Hospital of North Staffordshire NHS Trust
| | - J P Byrne
- University Hospital Southampton NHS Foundation Trust
| | - K L Pearson
- University Hospital Southampton NHS Foundation Trust
| | - T G Delisle
- University Hospital Southampton NHS Foundation Trust
| | - J Davies
- University Hospital Southampton NHS Foundation Trust
| | | | | | | | - A Macdonald
- University Hospital South Manchester NHS Foundation Trust
| | - J Nicholson
- University Hospital South Manchester NHS Foundation Trust
| | - K Newton
- University Hospital South Manchester NHS Foundation Trust
| | - J Mbuvi
- University Hospital South Manchester NHS Foundation Trust
| | - A Farooq
- Warrington and Halton Hospitals NHS Trust
| | | | - Z Zafrani
- Warrington and Halton Hospitals NHS Trust
| | - D Brett
- Warrington and Halton Hospitals NHS Trust
| | | | | | - J Barnes
- South Warwickshire NHS Foundation Trust
| | - M Cheung
- South Warwickshire NHS Foundation Trust
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - M Wadley
- Worcestershire Acute Hospitals NHS Trust
| | - E Hamilton
- Worcestershire Acute Hospitals NHS Trust
| | - S Jaunoo
- Worcestershire Acute Hospitals NHS Trust
| | - R Padwick
- Worcestershire Acute Hospitals NHS Trust
| | - M Sayegh
- Western Sussex Hospitals NHS Foundation Trust
| | - R C Newton
- Western Sussex Hospitals NHS Foundation Trust
| | - M Hebbar
- Western Sussex Hospitals NHS Foundation Trust
| | - S F Farag
- Western Sussex Hospitals NHS Foundation Trust
| | | | | | | | - C Blane
- Yeovil District Hospital NHS Trust
| | - M Giles
- York Teaching Hospital NHS Foundation Trust
| | - M B Peter
- York Teaching Hospital NHS Foundation Trust
| | - N A Hirst
- York Teaching Hospital NHS Foundation Trust
| | - T Hossain
- York Teaching Hospital NHS Foundation Trust
| | - A Pannu
- York Teaching Hospital NHS Foundation Trust
| | | | | | - G W Taylor
- York Teaching Hospital NHS Foundation Trust
| | | | | | | | | | | | | | | | | | | | | | | | | | - T Diamond
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - P Davey
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - C Jones
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - J M Clements
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - R Digney
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - W M Chan
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - S McCain
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - S Gull
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - A Janeczko
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - E Dorrian
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - A Harris
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - S Dawson
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - D Johnston
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | - B McAree
- Belfast City Hospital, Mater Infirmorum Hospital Belfast and Royal Victoria Hospital
| | | | | | | | | | | | | | | | | | | | | | | | | | - P Burke
- University Hospital Limerick
| | | | - A D K Hill
- Louth County Hospital and Our Lady of Lourdes Hospital
| | - E Khogali
- Louth County Hospital and Our Lady of Lourdes Hospital
| | - W Shabo
- Louth County Hospital and Our Lady of Lourdes Hospital
| | - E Iskandar
- Louth County Hospital and Our Lady of Lourdes Hospital
| | | | | | | | | | | | | | | | | | - P Balfe
- St Luke's General Hospital Kilkenny
| | - M Lee
- St Luke's General Hospital Kilkenny
| | - D C Winter
- St Vincent's University and Private Hospitals, Dublin
| | - M E Kelly
- St Vincent's University and Private Hospitals, Dublin
| | - E Hoti
- St Vincent's University and Private Hospitals, Dublin
| | - D Maguire
- St Vincent's University and Private Hospitals, Dublin
| | - P Karunakaran
- St Vincent's University and Private Hospitals, Dublin
| | - J G Geoghegan
- St Vincent's University and Private Hospitals, Dublin
| | - S T Martin
- St Vincent's University and Private Hospitals, Dublin
| | - F McDermott
- St Vincent's University and Private Hospitals, Dublin
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - S Gibson
- Crosshouse Hospital, Ayrshire and Arran
| | | | - D G Vass
- Crosshouse Hospital, Ayrshire and Arran
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - H C C Lim
- Glangwili General and Prince Philip Hospital
| | - D Duke
- Glangwili General and Prince Philip Hospital
| | - T Ahmed
- Glangwili General and Prince Philip Hospital
| | - W D Beasley
- Glangwili General and Prince Philip Hospital
| | | | - G Maharaj
- Glangwili General and Prince Philip Hospital
| | - C Malcolm
- Glangwili General and Prince Philip Hospital
| | | | | | | | - R Radwan
- Morriston and Singleton Hospitals
| | | | - S Wood
- Princess of Wales Hospital
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
191
|
Pedroso J, Taylor C, Sigala W, Kim A, Fang S, Azmat A, Gutierrez M, Brotherton J, Volker KW. Pathologic Findings in Women Undergoing Hysterectomy for Pelvic Pain. J Minim Invasive Gynecol 2016; 22:S232. [PMID: 27679129 DOI: 10.1016/j.jmig.2015.08.818] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- J Pedroso
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| | - C Taylor
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| | - W Sigala
- Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, Nevada
| | - A Kim
- Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, Nevada
| | - S Fang
- Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, Nevada
| | - A Azmat
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| | - M Gutierrez
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| | - J Brotherton
- Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, Nevada
| | - K W Volker
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| |
Collapse
|
192
|
Taylor C, Pedroso J, Gutierrez M, Volker KW. Squamous Cell Carcinoma in a Urethral Caruncle. J Minim Invasive Gynecol 2016; 22:S248. [PMID: 27679177 DOI: 10.1016/j.jmig.2015.08.866] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Affiliation(s)
- C Taylor
- Las Vegas Minimally Invasive Surgery-Women's Pelvic Health Center, Well Health Quality Care, Las Vegas, Nevada
| | - J Pedroso
- Las Vegas Minimally Invasive Surgery-Women's Pelvic Health Center, Well Health Quality Care, Las Vegas, Nevada
| | - M Gutierrez
- Las Vegas Minimally Invasive Surgery-Women's Pelvic Health Center, Well Health Quality Care, Las Vegas, Nevada
| | - K W Volker
- Las Vegas Minimally Invasive Surgery-Women's Pelvic Health Center, Well Health Quality Care, Las Vegas, Nevada
| |
Collapse
|
193
|
Pedroso J, Taylor C, Sigala W, Kim A, Fang S, Azmat A, Gutierrez M, Brotherton J, Volker KW. Occult Malignancy in Women Undergoing Hysterectomy for Pelvic Organ Prolapse. J Minim Invasive Gynecol 2016; 22:S244-S245. [PMID: 27679167 DOI: 10.1016/j.jmig.2015.08.855] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- J Pedroso
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| | - C Taylor
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| | - W Sigala
- Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, California
| | - A Kim
- Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, California
| | - S Fang
- Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, California
| | - A Azmat
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| | - M Gutierrez
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| | - J Brotherton
- Obstetrics and Gynecology, Harbor-UCLA Medical Center, Torrance, California
| | - K W Volker
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| |
Collapse
|
194
|
Pedroso JD, Gutierrez M, Taylor C, Volker KW. Laparoscopic Presacral Neurectomy: Anatomy and Surgical Technique. J Minim Invasive Gynecol 2016; 22:S126. [PMID: 27678676 DOI: 10.1016/j.jmig.2015.08.382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- J D Pedroso
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| | - M Gutierrez
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| | - C Taylor
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| | - K W Volker
- Gynecology, Las Vegas Minimally Invasive Surgery, Las Vegas, Nevada
| |
Collapse
|
195
|
Davis J, Shriver L, Taylor C, Ramsay S. Frequency of Eating Occasions and Relation to Weight Status in Children 2-5 Years of Age. J Acad Nutr Diet 2016. [DOI: 10.1016/j.jand.2016.06.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
196
|
Shriver L, Marriage B, Bloch T, Spees C, Ramsay S, Taylor C. Snacking Behaviors among Young Children: Examination of Snacking Across Racial/Ethnic Groups in the U.S. J Acad Nutr Diet 2016. [DOI: 10.1016/j.jand.2016.06.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
197
|
Asim M, Massie C, Warren A, Luko K, Chohan B, Menon S, Baridi A, Orafidiya F, Zhao W, Escriu C, Mohammed H, D’Santos C, Yang X, Taylor C, Qureshi A, Watt K, Zecchini V, Selth L, Dehm S, Mills I, Carroll J, Tilley W, McEwan I, Baniahmad A, Neal D. Abstract LB-003: Androgen-regulated proteome reveals a therapeutically relevant androgen receptor coactivator target in prostate cancer. Cancer Res 2016. [DOI: 10.1158/1538-7445.am2016-lb-003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Resistance to androgen deprivation therapy (ADT) and the development of castration resistant prostate cancer (CRPC) remains a major challenge in the treatment of advanced prostate cancer (PCa). Elucidation of resistance mechanisms leading to CRPC is essential to develop novel therapeutic interventions. Using a systems biology approach, we interrogated the androgen-regulated proteome and identified a mitotic Kinase as a novel androgen regulated kinase in PCa. The kinase was shown to be androgen-regulated in PCa and its nuclear localisation significantly increased in CRPC and was associated with biochemical relapse. Interestingly, the Kinase interacted directly with the amino terminus transactivation and carboxy terminus ligand binding domain of androgen receptor (AR), resulting in stabilisation of AR protein and its activity. The AR-driven global transcriptional program was regulated by this coactivator kinase including pathways involved in tumour invasion and metastasis. The inhibition of the kinase function decreased AR levels and activity, and slowed growth of PCa cell lines and human PCa explants. Thus the mitotic kinase is a novel AR-Stablised kinase with potential for clinical applications as both a candidate biomarker of PCa progression and a therapeutic target in advanced disease.
Citation Format: Mohammad Asim, Charlie Massie, Anne Warren, Katarina Luko, Brinder Chohan, Suraj Menon, Ajoeb Baridi, Folake Orafidiya, Wanfeng Zhao, Carlos Escriu, Hisham Mohammed, Clive D’Santos, Xiaoping Yang, Chris Taylor, Arham Qureshi, Kate Watt, Vincent Zecchini, Luke Selth, Scott Dehm, Ian Mills, Jason Carroll, Wayne Tilley, Iain McEwan, Aria Baniahmad, David Neal. Androgen-regulated proteome reveals a therapeutically relevant androgen receptor coactivator target in prostate cancer. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr LB-003.
Collapse
Affiliation(s)
- Mohammad Asim
- 1CR UK Cambridge Institute, Cambridge, United Kingdom
| | | | - Anne Warren
- 2Department of Pathology, Addenbrooke's Hospital, Cambridge, United Kingdom
| | - Katarina Luko
- 3Institute of Human Genetics, Jena University Hospital, Jena, Germany
| | - Brinder Chohan
- 2Department of Pathology, Addenbrooke's Hospital, Cambridge, United Kingdom
| | - Suraj Menon
- 1CR UK Cambridge Institute, Cambridge, United Kingdom
| | - Ajoeb Baridi
- 1CR UK Cambridge Institute, Cambridge, United Kingdom
| | - Folake Orafidiya
- 4School of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom
| | - Wanfeng Zhao
- 2Department of Pathology, Addenbrooke's Hospital, Cambridge, United Kingdom
| | - Carlos Escriu
- 1CR UK Cambridge Institute, Cambridge, United Kingdom
| | | | | | - Xiaoping Yang
- 1CR UK Cambridge Institute, Cambridge, United Kingdom
| | - Chris Taylor
- 1CR UK Cambridge Institute, Cambridge, United Kingdom
| | - Arham Qureshi
- 1CR UK Cambridge Institute, Cambridge, United Kingdom
| | - Kate Watt
- 4School of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom
| | | | - Luke Selth
- 5Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia
| | - Scott Dehm
- 6Masonic Cancer Centre, University of Minnesota, Minneapolis, MN
| | - Ian Mills
- 7Prostate Cancer UK/Movember Centre of Excellence, CCRCB, Queens University Belfast, Belfast, United Kingdom
| | - Jason Carroll
- 1CR UK Cambridge Institute, Cambridge, United Kingdom
| | - Wayne Tilley
- 5Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, Australia
| | - Iain McEwan
- 4School of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom
| | - Aria Baniahmad
- 3Institute of Human Genetics, Jena University Hospital, Jena, Germany
| | - David Neal
- 1CR UK Cambridge Institute, Cambridge, United Kingdom
| |
Collapse
|
198
|
Lim S, Sato T, Marino F, Stillitano F, Pioner JM, Haase T, Pianezzi E, Sivakumaran P, Hernandez D, Wong RCB, Taylor C, Dusting G, Pebay A, Bayeva M, Chang HC, Shapiro JS, Yar S, Ardehali H, Camporeale A, Avalle L, Heymans S, Roman B, Kotelianski V, Poli V, Karakikes I, Nonnenmacher M, Ceholski D, Zhang L, Hulot JS, Cai CL, Kranias EG, Hajjar RJ, Racca AW, Klaiman JM, Guan X, Pabon L, Muskheli V, Macadangdang J, Kim DH, Mack DL, Childers MK, Tesi C, Poggesi C, Murry CE, Regnier M, Krause J, Mueller C, Stenzig J, Roethemeier C, Wild PS, Blankenberg S, Zeller T, Altomare C, Cervio E, Bolis S, Moccetti T, Camici GG, Barile L, Vassalli GG. Moderated Poster session - Genetic, Epigenetic & Integrative480Inhibiting mitochondrial fission with Mdivi-1 directs cardiac differentiation of human induced pluripotent stem cells via protein kinase CK2481A novel role of tristetraprolin in preventing mitochondrial dysfunction in the heart against iron deficiency by optimizing expression of Rieske iron-sulfur protein482Different therapeutic approaches to downregulate the activation of the hepatic interleukin-6/stat3/complement pathway in two models of autoimmune myocarditis483In vitro and in vivo genome engineering of Dilated Cardiomyopathy caused by phospholamban R14 deletion.484Contractile dysfunction of induced pluripotent stem cell-derived cardiomyocytes from a duchenne muscular dystrophy patient485Cigarette smoking increases expression of the G protein-coupled receptor 15 mRNA by change in CpG methylation486Cardiogenic potential of iPSC from cardiac progenitor cells. Cardiovasc Res 2016. [DOI: 10.1093/cvr/cvw146] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
199
|
Lang P, Meis S, Procházková L, Carvalho L, Mackay EB, Woods HJ, Pottie J, Milne I, Taylor C, Maberly SC, Spears BM. Phytoplankton community responses in a shallow lake following lanthanum-bentonite application. Water Res 2016; 97:55-68. [PMID: 27085846 DOI: 10.1016/j.watres.2016.03.018] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/02/2015] [Revised: 02/19/2016] [Accepted: 03/07/2016] [Indexed: 06/05/2023]
Abstract
The release of phosphorus (P) from bed sediments to the overlying water can delay the recovery of lakes for decades following reductions in catchment contributions, preventing water quality targets being met within timeframes set out by environmental legislation (e.g. EU Water Framework Directive: WFD). Therefore supplementary solutions for restoring lakes have been explored, including the capping of sediment P sources using a lanthanum (La)-modified bentonite clay to reduce internal P loading and enhance the recovery process. Here we present results from Loch Flemington where the first long-term field trial documenting responses of phytoplankton community structure and abundance, and the UK WFD phytoplankton metric to a La-bentonite application was performed. A Before-After-Control-Impact (BACI) analysis was used to distinguish natural variability from treatment effect and confirmed significant reductions in the magnitude of summer cyanobacterial blooms in Loch Flemington, relative to the control site, following La-bentonite application. However this initial cyanobacterial response was not sustained beyond two years after application, which implied that the reduction in internal P loading was short-lived; several possible explanations for this are discussed. One reason is that this ecological quality indicator is sensitive to inter-annual variability in weather patterns, particularly summer rainfall and water temperature. Over the monitoring period, the phytoplankton community structure of Loch Flemington became less dominated by cyanobacteria and more functionally diverse. This resulted in continual improvements in the phytoplankton compositional and abundance metrics, which were not observed at the control site, and may suggest an ecological response to the sustained reduction in filterable reactive phosphorus (FRP) concentration following La-bentonite application. Overall, phytoplankton classification indicated that the lake moved from poor to moderate ecological status but did not reach the proxy water quality target (i.e. WFD Good Ecological Status) within four years of the application. As for many other shallow lakes, the effective control of internal P loading in Loch Flemington will require further implementation of both in-lake and catchment-based measures. Our work emphasizes the need for appropriate experimental design and long-term monitoring programmes, to ascertain the efficacy of intervention measures in delivering environmental improvements at the field scale.
Collapse
Affiliation(s)
- P Lang
- Ecology Assessment Unit, Scottish Environment Protection Agency, 6 Parklands Avenue, Maxim Business Park, Eurocentral, North Lanarkshire ML1 4WQ, Scotland, UK.
| | - S Meis
- Freshwater Ecology Group, Centre for Ecology & Hydrology, Bush Estate, Penicuik, Midlothian EH26 0QB, Scotland, UK
| | - L Procházková
- Department of Ecology, Faculty of Science, Charles University in Prague, Viničná 7, CZ-128 44 Prague, Czech Republic
| | - L Carvalho
- Freshwater Ecology Group, Centre for Ecology & Hydrology, Bush Estate, Penicuik, Midlothian EH26 0QB, Scotland, UK
| | - E B Mackay
- Lake Ecosystems Group, Centre for Ecology & Hydrology, Lancaster Environment Centre, Library Avenue, Bailrigg, Lancaster LA1 4AP, England, UK
| | - H J Woods
- Freshwater Ecology Group, Centre for Ecology & Hydrology, Bush Estate, Penicuik, Midlothian EH26 0QB, Scotland, UK
| | - J Pottie
- Broombank, Loch Flemington, Inverness IV2 7QR, Scotland, UK
| | - I Milne
- Ecology Partnership Development Unit, Scottish Environment Protection Agency, Graesser House, Fodderty Way, Dingwall Business Park, Dingwall IV15 9XB, Scotland, UK
| | - C Taylor
- Ecology Assessment Unit, Scottish Environment Protection Agency, 6 Parklands Avenue, Maxim Business Park, Eurocentral, North Lanarkshire ML1 4WQ, Scotland, UK
| | - S C Maberly
- Lake Ecosystems Group, Centre for Ecology & Hydrology, Lancaster Environment Centre, Library Avenue, Bailrigg, Lancaster LA1 4AP, England, UK
| | - B M Spears
- Freshwater Ecology Group, Centre for Ecology & Hydrology, Bush Estate, Penicuik, Midlothian EH26 0QB, Scotland, UK
| |
Collapse
|
200
|
Samuel M, Samarawickrama A, Sahota A, Taylor C, Brady M. P167 Managing rectal GC : room for improvement. Br J Vener Dis 2016. [DOI: 10.1136/sextrans-2016-052718.217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|